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Key	Points:	15	
• The	evolution	of	mammalian	pathogenesis	in	the	Yersinia	genus	has	16	 occurred	in	a	parallel	fashion	via	a	balanced	mixture	of	gene	gain	and	gene	loss	17	 events	18	
• Only	by	sequencing	pathogenic	and	non	pathogenic	representatives	19	 positioned	across	an	entire	bacterial	genus	can	such	observations	be	made	20	
• The	parallel	nature	of	the	evolution	of	pathogenesis	extends	beyond	21	
Yersinia	and	into	other	enteric	pathogens,	notably	the	salmonellae	22	
• Gene	loss	events	lead	to	niche	restriction	due	to	a	reduction	in	metabolic	23	 flexibility,	often	seen	in	the	more	acutely	pathogenic	members	of	a	lineage	24	
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• Potential	negative	impacts	of	gene	gain	events	are	offset	by	the	1	 transcriptional	silencing	or	fine	control	of	these	acquired	elements	by	ancestral	2	 regulons	such	as	RovA	and	H-NS.		 	3	
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Abstract	1	 In	the	study	of	molecular	microbiology	and	bacterial	genetics,	pathogenic	species	2	 of	the	Yersinia	genus	have	been	pillars	for	research	aimed	at	understanding	how	3	 bacteria	evolve	into	mammalian	pathogens.	The	advent	of	large-scale	population	4	 genomic	studies	has	hugely	accelerated	progress	in	this	field,	and	the	pathogenic	5	
Yersinia	 species	 have	 re-emerged	 as	 model	 organisms	 to	 help	 shape	 our	6	 understanding	 of	 the	 evolutionary	 processes	 involved	 in	 pathogenesis.	 In	 this	7	 review,	 we	 highlight	 how	 microbial	 genomic	 studies	 of	 the	 yersiniae	 have	8	 revealed	distinct	features	marking	the	evolutionary	path	towards	pathogenesis,	9	 which	are	changing	our	understanding	of	pathogen	evolution.	As	these	features	10	 are	also	found	in	the	genomes	of	other	members	of	the	Enterobacteriaceae,	they	11	 provide	a	blueprint	for	the	evolution	of	enteropathogenic	bacteria.		12	 	 	13	
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Introduction	1	 The	 ever-expanding	 microbial	 genome	 sequence	 dataset,	 combined	 with	 an	2	 increased	understanding	of	the	pathogenesis	and	ecology	of	bacterial	pathogens,	3	 is	 illuminating	 our	 view	 of	 the	 dynamics	 that	 have	 shaped	 the	 evolution	 of	4	 bacterial	 pathogens.	 It	 is	 now	 evident	 that	 many	 bacterial	 pathogens	 infect	5	 humans	 only	 incidentally	 and	 often	 produce	 virulence	 factors	 that	 are	 active	6	 against	non-mammalian	adversaries	as	diverse	as	insects,	protozoa,	nematodes,	7	 predatory	 bacteria	 and	 bacteriophage1–3.	 These	 hosts	 provide	 a	 considerable	8	 driving	 force	 in	 the	evolution	of	bacterial	pathogens	enabling	us	 to	 re-evaluate	9	 human—pathogen	 interactions	 in	 the	 light	 of	 bacterial	 ecology	 and	 evolution	10	 (the	eco-evo	perspective).	A	consequence	of	the	eco–evo	perspective	is	that	it	is	11	 not	surprising	that	genes	encoding	‘virulence	factors’	are	found	in	pathogens	and	12	 non-pathogens	 colonizing	 diverse	 mammalian	 and	 non-mammalian	 hosts4,5.	13	 Conversely,	 as	 bacteria	 evolve	 to	 inhabit	 new	 hosts,	 or	 new	 niches	within	 the	14	 same	hosts,	using	genomics	we	can	see	remnants	of	genes	and	gene	clusters	that	15	 are	thought	to	have	provided	an	adaptive	advantage	in	the	past,	but	that	are	now	16	 non-functional	and	represent	evolutionary	baggage.		17	 Thus,	many	bacteria	seem	to	be	pre-armed	with	virulence	determinants	as	they	18	 traverse	 new	 environments	 and	 niches,	 and	 their	 evolution	 is	 not	 solely	19	 dependent	 on	 mammalian/human–pathogen	 interactions6,7.	 The	 yersiniae	20	 represent	a	genus	for	which	the	eco-evo	perspective	is	highly	pertinent	and	for	21	 which	 all	 18	 species	 in	 the	 genus	 have	 recently	 been	 fully	 sequenced,	22	 metabolically	 phenotyped	 and	 compared8.	 The	 genus	 includes	 both	 non-23	 pathogenic	and	pathogenic	species,	and	a	diversity	of	pathogenesis	phenotypes	24	 so	it	represents	a	key	model	for	understanding	the	forces	at	play	in	the	evolution	25	
5		
of	pathogenic	bacteria.	Our	current	understanding	of	the	Yersinia	encompasses	a	1	 long-term	 view	 of	 how	 broad	 host	 range	 pathogenic	 species	 such	 as	 Yersinia	2	
enterocolitica	 evolve	over	millions	of	years	 from	a	non-pathogenic	ancestor9.	 It	3	 also	 encompasses	 short	 term	 evolution	 examining	 how	 recent	 evolutionary	4	 bottlenecks	 have	 led	 to	 rapid	 emergence	 of	 high-pathogenic	 clones	 from	 their	5	 ancestral	 lineage	 such	 as	 the	 emergence	 of	 Yersinia	 pestis	 from	 Yersinia	6	
pseudotuberculosis10.		7	 The	 evolution	 of	 pathogenic	 Yersinia	 spp.	 shows	 remarkable	 parallels	 with	8	 members	of	the	genus	Salmonella,	which	encompasses	the	broad	host	range	self-9	 limiting	diarrheagenic	Salmonella	enterica	subsp.	enterica	serovar	Typhimurium	10	 (S.	 Typhimurium)	 as	 well	 as	 those	 that	 are	 host	 restricted	 and	 acutely	11	 pathogenic,	such	as	Salmonella	enterica	subsp.	enterica	serovar	Typhi	(S.	Typhi).	12	 This	has	also	made	the	pathogenic	Yersinia	species	organisms	of	choice	for	much	13	 of	 the	 pioneering	work	 performed	 understanding	 the	mechanisms	 of	 bacterial	14	 pathogenesis	through	classical	genetics.	Studies	using	Y.	enterocolitica	have	been	15	 at	 the	 forefront	 of	 developing	 our	 understanding	 of	 how	 bacteria	 invade	 host	16	 epithelial	 cells11.	 Studies	 of	 the	 pathogenic	 Yersinia	 also	 forged	 our	17	 understanding	of	the	role	of	plasmids	in	bacterial	virulence12,13,	the	identification	18	 and	 characterization	 of	 Type	 III	 secretion	 systems	 and	 their	 role	 in	 host	19	 subversion14.	This	in	turn	led	to	advances	in	our	understanding	of	how	bacteria	20	 evade	host	responses	during	infection15–17.	21	 In	 this	 Review,	we	 examine	 how	 the	 eco-evo	 perspective,	 informed	 by	whole-22	 genome	 sequencing	 and	 by	 population	 genomic	 and	 ecological	 studies,	 has	23	 challenged	previous	hypotheses	on	the	evolution	of	mammalian	pathogenesis	in	24	
Yersinia	spp.	Furthermore,	we	consider	how	these	studies	are	revealing	common	25	
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principles	 in	 the	 emergence	 of	 pathogenesis	 among	 other	 Enterobacteriaceae.	1	 Finally,	we	show	how	considering	all	members	of	a	genus	in	population	genomic	2	 studies,	 and	 not	 just	 pathogenic	 species,	 can	 provide	 greater	 insight	 and	3	 resolution	 for	 understanding	 of	 the	 processes	 underpinning	 the	 evolution	 of	4	 mammalian	pathogenesis.			5	
	6	
The	yersiniae	7	 The	 Yersinia	 is	 a	 genus	 of	 Gram-negative	 bacteria	 belonging	 to	 the	8	
Enterobacteriaceae.	 The	 genus	 nomenclature	 is	 based	 on	 classical	 systematics	9	 and	 biochemical	 speciation	 methods,	 resulting	 in	 a	 highly	 diverse	 group	 of	10	 bacteria	 with	 18	 defined	 species18–26.	 The	 best	 characterized	 of	 these	 are	 the	11	 three	 species	 that	 cause	 disease	 in	 humans:	 Y.	 enterocolitica	 and	 Y.	12	
pseudotuberculosis	are	zoonotic	pathogens	that	cause	self-limiting	gastroenteritis	13	 in	humans,	whereas	Y.	pestis	 is	 a	 rodent	 and	 flea	pathogen	 that	 is	 occasionally	14	 transmitted	to	humans	and	is	the	causative	agent	of	plague27.	The	remaining	15	15	 known	species	of	this	genus	are	commonly	found	in	soil	and	water	environments	16	 and	are	generally	 considered	 to	be	non-pathogenic	 to	humans,	 though	Yersinia	17	
ruckeri	 is	 the	causative	agent	of	 red	mouth	disease	 in	salmonids21	and	Yersinia	18	
entomophoga	 has	 insecticidal	 activity24.	 Recent	 phylogenomic	 analysis	 of	 the	19	 entire	 Yersinia	 genus	 allowed	 for	 an	 accurate,	 whole	 genome	 SNP-based,	20	 assessment	of	 its	population	structure8,	showing	there	were	14	distinct	species	21	 complexes	within	 the	genus.	This	 robust	 sequenced	based	 taxonomy	disagreed	22	 with	 the	 standing	 taxonomic	 description	 of	 the	 genus,	 based	 largely	 on	23	 biochemical	 differences.	 It	 also	 showed	 that	 the	 mammalian	 pathogenic	 Y.	24	
enterocolitica	species	and	Y.	pseudotuberculosis	species	complex	(also	containing	25	
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Y.	pestis	and	Y.	similis)	fell	at	opposite	ends	of	the	Yersinia	phylogenic	spectrum	1	 (Box	1)	and	did	not	branch	together	as	was	previously	thought.	2	 Early	microbial	 population	 genetics	 studies	 showed	 that	 Y.	pestis	 is	 a	 recently	3	 emerged	clone	of	 the	enteropathogen	Y.	pseudotuberculosis,	yet	has	a	markedly	4	 different	 lifestyle	 and	 causes	 a	much	more	 acute	 disease28,29. The	 evolutionary	5	 narrative	 tells	 how	 Y.	pestis	 evolved	 from	 the	 gastrointestinal	 pathogen,	 in	 an	6	 evolutionary	blink	of	 an	eye	 (estimated	 to	be	between	2,000	and	10,000	years	7	 ago28,30)	 through	 the	 processes	 of	 gene	 gain,	 gene	 loss	 and	 genome	8	 rearrangements. This	 finding	 was	 further	 explored	 with	 early	 microbial	9	 comparative	genomics	studies.	These	revealed	that	Y.	pestis	had	emerged	from	Y.	10	
pseudotuberculosis	 through	 a	mixture	 of	 both	 gene	 gain	 events,	 in	 the	 form	 of	11	 acquisition	 of	 species-specific	 plasmids,	 bacteriophage,	 integrons	 and	 genomic	12	 islands,	 as	 well	 as	 multiple	 complete	 or	 partial	 gene	 loss	 events	 leading	 to	 a	13	 reduction	 in	 genomic	 flexibility	 and	 metabolic	 streamlining.	 All	 of	 this	 is	14	 associated	with	 its	 change	 in	 lifestyle	and	ultimate	niche	 restriction10,31–33.	The	15	 relationship	 of	 Y.	enterocolitica	 to	 the	 Y.	pseudotuberculosis—Y.	pestis	 complex	16	 was	 until	 recently	 poorly	 defined.	 In	 2006,	 a	 comparison	 of	 the	 available	17	 genomes	from	all	three	species	suggested	that	they	shared	a	distant	but	common	18	 pathogenic	 ancestor	 which	 had	 acquired	 key	 pathogenicity	 determinants	19	 including	 the	essential	virulence	plasmid	pYV,	encoding	Ysc	 the	prototype	 type	20	 III	 secretion	 system	 (T3SS),	 before	 splitting	 into	 distinct	 lineages9,27.	 However,	21	 the	 availability	 of	 just	 a	 single	 Y.	enterocolitica	 genome	 sequence	 at	 this	 time	22	 limited	 the	 interpretations	 that	 could	 be	 made.	 Further	 genomes	 were	23	 subsequently	 published	 for	 Y.	 enterocolitica	 in	 2011	 and	 201334–37,	 as	 well	 as	24	 singular	 genomes	 for	 type	 strains	 of	 environmental	 species	 in	 201038	 but	 our	25	
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understanding	of	 the	evolution	of	 this	whole	genus	and	where	Y.	enterocolitica	1	 fitted	into	the	evolutionary	scale	of	Yersinia	species	was	still	limited	by	the	lack	2	 of	 comprehensive	 whole	 genome	 data.	 Nonetheless,	 even	 with	 this	 limited	3	 genomic	 data,	 a	 combination	 of	 gene	 gain	 and	 gene	 loss	 in	 the	 three	 human	4	 pathogenic	 Yersinia	 species	 was	 evident	 and	 highlighted	 the	 complexity	 of	5	 evolution	of	mammalian	pathogenicity	in	these	bacteria,	showing	that	pathogens	6	 can	evolve	by	a	process	of	“add	DNA,	stir,	and	reduce”27.		7	 The	 study	 of	 the	 evolution	 of	 pathogenesis	 in	 the	 genus	 also	 suggested	 an	8	 inexorably	 distinct	 relationship	 between	 loss	 of	metabolic	 function	 by	 genome	9	 decay,	 reduction	 in	 ecological	 flexibility,	 and	 the	 evolution	 towards	 niche-10	 restricted	 highly	 pathogenic	 lineages27.	 As	 population	 genomic	 studies	 have	11	 become	an	established	tool	 in	microbiology,	the	level	of	resolution	at	which	we	12	 can	 study	 these	 evolutionary	 events	 has	 improved	 considerably.	 By	 genome	13	 sequencing	 across	 entire	 bacterial	 genera	 it	 is	 possible	 to	 determine	 the	 key	14	 acquisition	and	 loss	events	 in	 the	evolution	of	bacterial	pathogenesis.	 It	 is	also	15	 possible	to	shed	new	light	on	the	evolutionary	forces	and	patterns	underpinning	16	 these	processes,	and	identify	their	common	features	across	bacterial	genera.		17	
	18	
The	role	of	gene	gain		19	 The	 evolutionary	path	 from	environmental	 or	 commensal	 bacterium	 to	human	20	 pathogen	has	long	been	associated	with	the	gain	of	mobile	genetic	elements	via	21	 horizontal	 gene	 transfer,	 through	 phage	 transduction,	 plasmid	 uptake,	 natural	22	 transformation	and	DNA	conjugation.	In	the	Yersinia	genus	there	seems	to	have	23	 been	‘foothold	moments’	characterized	by	acquisitions	that,	looking	back	across	24	 the	 genus	 phylogeny	 appear	 as	 pivotal	 steps	 in	 the	 emergence	 of	 mammalian	25	
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pathogenic	 lineages.	 The	 most	 important	 of	 these	 seems	 to	 have	 been	 the	1	 acquisition	of	 the	 family	of	pYV	virulence	plasmids	encoding	 the	Ysc	prototype	2	 T3SS8,12,13,39.	The	Ysc	T3SS	delivers	Yop	effector	proteins	directly	into	host	cells	3	 upon	contact,	 resulting	 in	 the	cessation	of	actin	polymerization	 for	endocytosis	4	 (which	 promotes	 bacterial	 uptake)	 and	 in	 the	 suppression	 of	 host-cell	5	 transcription40.	 Following	 contact	with	 host	macrophages,	 the	 activities	 of	 Yop	6	 effectors	silence	 the	 innate	 immune	response,	 resulting	 in	 the	down-regulation	7	 of	 pro-inflammatory	 cytokine	 production	 and	 allowing	 proliferation	 of	 the	8	 infection41–43,	a	process	termed	the	“Yersinia	deadly	kiss”.		9	 The	 advantage	 of	 sequencing	 broadly	 across	 a	 genus	 and	 deep	 within	 each	10	 species	is	that	the	origins	and	distribution	of	all	genes	described	as	Yersinia	spp.	11	 virulence	 factors,	 or	otherwise,	 in	 the	published	 literature	 can	be	ascertained8.	12	 Such	an	analysis	 confirmed	 that	pYV	was	one	of	 only	 two	virulence-associated	13	 genetic	 loci	 that	were	uniquely	present	 in	all	 three	Yersinia	 lineages	commonly	14	 associated	with	mammalian	 disease	 (pYV	 is	 absent	 from	Yersinia	 species	 non-15	 pathogenic	to	mammals).	The	other	was	the	chromosomally	encoded	attachment	16	 and	 invasion	 locus	 ail	 which	 has	 a	 role	 in	 the	 attachment	 to,	 and	 invasion	 of,	17	 mammalian	 epithelial	 cells	 as	 well	 as	 in	 resistance	 to	 killing	 by	 the	 host	18	 complement	system44–46.	The	pivotal	role	of	pYV	in	the	emergence	of	mammalian	19	 pathogenesis	 is	 highlighted	 by	 the	 revelation	 that,	 contrary	 to	 accepted	20	 wisdom9,27,47,	 closely	 related	 versions	 of	 this	 plasmid	 were	 acquired	21	 independently	on	at	 least	 three	occasions	 in	 the	Yersinia	genus;	 twice	by	the	Y.	22	
enterocolitica	and	once	by	the	Y.	pseudotuberculosis—Y.	pestis	lineage8,	and	that	23	
Y.	 enterocolitica	 did	 not	 share	 a	 common	 pathogenic	 ancestor	 with	 Y.	24	
pseudotuberculosis	as	previously	thought8.	As	such,	multiple	independent	ail	and	25	
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pYV	 acquisitions	 were	 key	 gene	 gain	 events	 that	 marked	 the	 parallel	1	 independent	evolution	of	mammalian	pathogenesis	in	the	Yersinia	genus.	This	is	2	 surprising	 if	one	considers	the	 large	number	of	virulence-associated	genes	that	3	 have	 been	 reported	 in	 Yersinia	 based	 on	 published	 classic	 bacterial	 genetics	4	 experiments.	This	 includes	key	virulence	 factors	such	as	 Invasin48,	 the	Fes/Fep	5	 iron	acquisition	 system49,	 the	Tad	 type	 IVb	pilus50	 and	Myf	 fimbriae51,	 and	 the	6	 Yst	heat	stable	toxin52,	all	of	which	are	widely	distributed	across	pathogenic	and	7	 non-pathogenic	members	of	the	genus.	This	could	be	explained	through	the	eco-8	 evo	 perspective	 whereby	 the	 environmental	 yersiniae	may	 have	 acquired	 and	9	 maintained	 some	 virulence	 factors	 to	 combat	 predatory	 protozoa,	 nematodes,	10	 predatory	bacteria,	and	bacteriophage	or	even	to	colonise	plants.	This	highlights	11	 the	 benefits	 of	 studying	 the	 accessory	 gene	 pool	 of	 pathogenic	 bacteria	 in	 the	12	 wider	context	of	the	genera	they	belong	to,	a	strategy	that	has	yet	to	be	widely	13	 applied	 to	 other	 enteric	 pathogens.	 Indeed	 in	 order	 to	 confirm	 the	 eco-evo	14	 hypothesis	there	is	also	a	benefit	and	need	to	study	the	role	of	virulence	genes	in	15	 these	non-pathogenic	isolates	to	allow	us	to	fully	determine	the	true	ecology	of	16	 bacterial	species.	17	 In	 addition	 to	 the	 crucial	 gains	 of	 the	 pYV	 plasmid	 and	 ail	 locus	 in	 all	 three	18	 human	 pathogenic	 Yersinia	 spp.,	 a	 number	 of	 other	 acquired	 loci	 have	 been	19	 maintained	 by	 clonal	 expansion	 in	 individual	 Yersinia	 species	 complexes	 and	20	 phylogroups	 (PG).	 Perhaps	 the	 most	 striking	 and	 formative	 of	 these	 is	 the	21	 acquisition	 of	 the	 pFra	 (pMT1)	 and	 pPla	 (pPCP1)	 plasmids	 of	 Y.	pestis,	 which	22	 encode	the	murine	toxin	Ymt	and	the	F1	capsular	protein	and	the	plasminogen	23	 activator	Pla.	The	acquisition	of	these	two	plasmids	is	a	significant	event	 in	the	24	 move	towards	efficient	insect	vector-mammalian	transmission	of	Y.	pestis,53	and	25	
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Pla	has	recently	been	shown	to	be	pivotal	for	causing	the	fulminant	pneumonic	1	 infection	 unique	 to	 Y.	pestis	 within	 the	 Yersinia	 genus54.	 Also	 in	 this	 group	 of	2	 acquired	 elements	 is	 the	 High	 Pathogenicity	 Island	 (HPI).	 HPI	 is	 a	 large	3	 integrative-conjugative	 element	 capable	 of	 excision	 and	 transfer	 via	 the	 use	 of	4	 self	encoded	integrase	and	excision	factors55.	As	such	the	HPI	is	often	found	in	a	5	 range	of	bacterial	genera	including	extra-intestinal	pathogenic	E.	coli56.	The	HPI	6	 encodes	 the	 siderophore	 yersiniabactin	 that	 sequesters	 iron	 in	 the	 host56,57,	7	 imports	 zinc	 into	 bacterial	 cells58,	 and	 assists	 in	 reducing	 the	 respiratory	8	 oxidative	burst	response	of	immune	cells59.	Within	Yersinia	spp.,	HPI	containing	9	 a	 fully	 functioning	 yersiniabactin	 is	 found	 only	 in	 strains	 belonging	 to	 the	 Y.	10	
pseudotuberculosis—Y.	 pestis	 species	 complex,	 where	 its	 presence	 is	 isolate	11	 dependant,	 and	 in	 the	 highly	 virulent	 phylogroup	 2	 lineage	 of	 the	 Y.	12	
enterocolitica	species	complex,	where	it	is	uniformly	present.	The	key	remaining	13	 gene	 acquisition	 events	 that	 have	 occurred	 in	 the	 pathogenic	members	 of	 the	14	 genus	involve	the	Ysa	T3SS	by	phylogroup	2	Y.	enterocolitica,	and	Hms	by	the	Y.	15	
pseudotuberculosis—Y.	 pestis	 species	 complex.	 The	 Ysa	 T3SS	 is	 located	 in	 a	16	 region	 of	 the	 genome	 known	 as	 the	 plasticity	 zone60,	 first	 identified	 in	 the	17	 archetypal	 phylogroup	 2	 strain	 80819.	 The	 plasticity	 zone	 is	 a	 region	 of	 the	Y.	18	
enterocolitica	genome	that	shows	signs	of	multiple	independent,	and	phylogroup	19	 specific	acquisitions	and	deletions9.	Ysa	T3SS	has	been	shown	to	secrete	a	large	20	 number	of	 chromosomally	encoded	T3SS	effector	proteins61	as	well	as	 the	Yop	21	 T3SS	effector	proteins	of	the	Ysc	system	carried	on	pYV62.	Although	mutagenesis	22	 studies	 suggest	 ysa	 plays	 only	 a	 minor	 role	 in	 mammalian	 pathogenesis61,	23	 consistent	 with	 the	 eco-evo	 perspective,	 ysa	 mutants	 were	 shown	 to	 be	24	 attenuated	 in	 their	 ability	 to	 survive	 inside	 cultured	 Drosophila	melanogaster	25	
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cells	 suggesting	 ysa	 is	 more	 important	 outside	 of	 the	 mammalian	 host	 for	1	 phylogroup	2	Y.	enterocolitica63.	 	The	Hms	 locus	 is	 located	on	 the	chromosome	2	 and	encodes	a	hemin	storage	locus	that	is	unique	to	the	Y.	pseudotuberculosis-Y.	3	
pestis	 lineage	 and	 is	 responsible	 for	 its	 ability	 to	 form	 pigmented	 colonies	 on	4	 congo-red	agar64.	Hms	is	important	for	Y.	pestis	pathogenesis	as	it	is	responsible	5	 for	 formation	 of	 biofilms,	 required	 for	 the	 blockage	 of	 the	 flea	 foregut,	 which	6	 facilitates	 its	 subsequent	 transmission	 to	 mammals	 through	 reflux	 of	 infected	7	 blood	from	the	infected	feeding	flea	back	onto	the	bite	site65.		8	 	9	
Regulatory	control	10	 Although	 the	acquisition	of	mobile	 genetic	 elements	has	been	a	key	process	 in	11	 the	 emergence	 of	 Yersinia	 spp.	 pathogenesis,	 loci	 are	more	 likely	 to	 be	 stably	12	 maintained	in	a	population	if	there	is	a	minimal	fitness	cost	to	their	integration	13	 into	the	genome	of	the	host	bacterium,	or	a	high	selective	pressure	for	them	to	14	 be	 maintained.	 To	 achieve	 this,	 many	 acquired	 elements	 fall	 under	 strict	15	 transcriptional	 and/or	 translational	 control	 to	 minimise	 the	 fitness	 costs	16	 associated	with	 their	acquisition.	Across	 the	Enterobacteriaceae	many	acquired	17	 genetic	 elements	 are	 regulated	 by	 H-NS,	 a	 nucleoid	 associated,	 histone-like	18	 protein	that	binds	to	A-T	rich	regions	of	DNA	silencing	transcriptional	activity66.	19	 Once	under	 the	strict	negative	control	of	H-NS,	 the	acquired	elements	are	 then	20	 integrated	 into	 existing	 transcriptional	 activating	 regulons	within	 the	 bacterial	21	 cell.	 These	 function	 in	 an	 antagonistic	 fashion	with	H-NS	 to	 tightly	 control	 the	22	 transcriptional	 expression	 of	 the	 new	 genes.	 In	 the	 case	 of	 Yersinia	 spp.,	 the	23	 chromosomal	 rovA/ymoA	 regulon	has	been	 suggested	 to	 fulfil	 this	 antagonistic	24	 role	 to	 H-NS8,67.	 The	 rovA	 gene	 is	 universally	 present	 across	 the	 genus8	 and	25	
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encodes	a	member	of	the	MarR/SlyA	family	of	global	transcriptional	regulators67.	1	 It	 is	 known	 to	 antagonise	H-NS	 silencing	 of	 the	 invasin	 protein	 gene,	 invA,	 the	2	 product	 of	which	 is	 involved	 in	 the	 early	 stages	 of	Yersinia	spp.	 attachment	 to	3	 cells	and	 internalization	during	 infection.	The	binding	of	RovA	to	 the	promoter	4	 region	masks	the	H-NS	binding	site,	triggering	transcription68.	Genes	rovA/ymoA	5	 are	 thought	 to	 encode	 a	 promiscuous	 ancestral	 regulon	 into	 which	 the	6	 expression	of	acquired	genes	were	 incorporated	multiple	 times	 in	 the	different	7	 lineages	 (FIG	 1).	 This	 is	 thought	 to	 explain	why	 RovA	regulates	 different	 gene	8	 sets	 in	Y.	enterocolitica	and	Y.	pseudotuberculosis/pestis67,69:	RovA	was	shown	to	9	 transcriptionally	activate	73	genes	 in	Y.	pestis	 and	63	genes	 in	Y.	enterocolitica,	10	 but	 only	 three	 genes	 were	 common	 to	 both	 species67.	 The	 majority	 of	 RovA	11	 controlled	 genes	 are	 lineage-specific	 virulence	 factors	 such	 as	 Invasin	 or	 Myf	12	 fimbriae,	 or	 lineage	 specific	 prophage	 or	 metabolic	 genes67.	 The	 rovA/ymoA	13	 regulon	 also	 controls	 the	 expression	 of	 genes	 encoded	 on	 the	 pYV	 plasmid,	14	 highlighting	its	importance	as	a	global	regulator	of	virulence.		15	 The	 expression	 of	 the	 Yop	 proteins	 encoded	 on	 pYV	 is	 down-regulated	 at	 a	16	 transcriptional	level	by	LcrF	(an	ortholog	of	HN-S,	encoded	on	the	pYV	plasmid),	17	 in	response	to	the	mammalian	environment.	Recent	work	has	identified	that	this	18	 regulation	 is	 controlled	 at	 a	 hierarchical	 level	 by	 YmoA,	 which	 functions	 as	 a	19	 thermo-sensing	 switch	 to	 turn	 off	 lcrF	 transcription,	 and	 therefore	 Yop	20	 translation	 and	 secretion	 at	 low	 temperatures70,	 and	 by	 Hfq	 and	 other	 small	21	 regulatory	RNAs	conserved	 in	 the	Yersinia	genus71.	This	 thermo-sensing	switch	22	 is	 a	 tandem	 process	 which	 relies	 on	 weak	 binding	 of	 YmoA	 directly	 to	 the	23	 promoter	region	of	lcrF	at	low	temperatures	and	the	formation	of	a	double	stem	24	 loop	 in	 the	 intergenic	 region	 resulting	 in	 stearic	hindrance	of	RNA	polymerase	25	
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binding	 and	 formation	 of	 transcripts70,72.	 Overall	 the	 importance	 of	 the	1	 RovA/YmoA	system	for	the	evolution	of	pathogenesis	in	Yersinia	is	evident	from	2	 these	 data:	 At	 temperatures	 below	 37OC	 virulence	 factors,	 essential	 for	3	 mammalian	pathogenesis,	are	not	expressed	because	RovA/YmoA	is	inactive	and	4	 they	are	repressed	by	H-NS.	However	flagella	biosynthesis	genes	(in	the	case	of	5	 the	 enteropathogenic	 species)	 or	 insect	 transmission	 loci	 such	 as	 hms	 (in	 the	6	 case	 of	 Y.	pestis)	are	 expressed	 at	 high	 levels73,74.	 Upon	 a	 shift	 to	 mammalian	7	 body	temperatures	essential	acquired	virulence	factors	such	as	those	on	pYV,	ail	8	 and	 invA	 are	 activated	 by	 RovA/YmoA.	Other	 environmental	 triggers	 are	 also	9	 known	to	influence	this	regulatory	cascade	such	as	levels	of	exogenous	calcium	10	 ions75	 or	 levels	 of	 exogenous	 magnesium	 ions	 via	 the	 PhoPQ	 two	 component	11	 regulatory	 system76.	 Indeed	 PhoPQ	 has	 been	 shown	 to	 have	 an	 overarching	12	 control	on	levels	of	RovA	and	as	such	a	key	role	in	virulence	phenotypes	in	all	3	13	 human	pathogenic	species77–79.	14	 The	 presence	 of	 an	 ancestral	 promiscuous	 regulatory	 system	 controlling	15	 expression	of	acquired	genes	involved	in	virulence	draws	striking	parallels	with	16	
Salmonella	spp.	The	key	acquisition	event	in	the	evolution	of	pathogenesis	in	the	17	
Salmonella	 genus	 was	 Salmonella	 pathogenicity	 island-1	 (SPI-1).	 This	18	 pathogenicity	 island	 encodes	 a	T3SS	 and	 its	 cognate	 secreted	 effector	proteins	19	 that	remodel	the	actin	cytoskeleton	of	infected	cells	and	force	uptake	of	attached	20	 bacteria	 into	 endocytic	 vacuoles.	 As	 with	 pYV,	 the	 acquisition	 of	 SPI-1	 was	 a	21	 landmark	event	 in	the	evolution	of	 the	Salmonella	genus,	being	present	 in	both	22	 species:	 S.	 enterica	 and	 Salmonella	 bongori80.	 SPI-1	 is	 under	 negative	23	 transcriptional	control	by	H-NS.	Similar	to	Yersinia,	H-NS-mediated	repression	of	24	 SPI-1	 functions	 is	 alleviated	 by	 the	 concerted	 action	 of	 a	 number	 of	25	
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transcriptional	 regulators	 including	 HilD/HilA,	 SlyA	 which	 is	 an	 ortholog	 of	1	 RovA,	and	the	two-component	regulatory	system	PhoPQ81.	Recent	work	showed	2	 that	SPI-1	was	readily	lost	 in	Salmonella	H-NS	null	mutants,	Showing	that	H-NS	3	 silencing	of	SPI-1	was	likely	to	have	been	an	essential	 factor	 in	SPI-1	becoming	4	 fixed	 in	all	Salmonella	spp.	and	so	the	evolution	of	pathogenesis	 in	members	of	5	 this	genus	too82.			6	 Therefore	 it	 seems	 that	an	emerging	 theme	 in	 the	evolution	of	pathogenesis	 in	7	 enteric	bacteria	is	not	only	the	pivotal	acquisition	of	one	or	two	key	genetic	loci,	8	 but	also	the	co-ordinated	transcriptional	control	of	those	acquired	loci	by	H-NS	9	 and	other	species-specific	promiscuous	global	regulators.		10	
	11	
Role	of	gene	loss	12	 Although	the	importance	of	gene	gain	in	the	evolution	of	bacterial	pathogenicity	13	 is	 intuitive	and	well	documented,	 the	role	of	gene	 loss	and	host	adaptation	has	14	 been	 shown	 to	 be	 central	 in	 the	 emergence	 of	 bacterial	 pathogens83.	 The	15	 majority	 of	work	 looking	 at	 the	 evolution	 of	 pathogenesis	 in	Yersinia	 spp.	 has	16	 focused	on	the	evolutionary	events	that	led	to	the	emergence	of	Y.	pestis	from	Y.	17	
pseudotuberculosis28.	 Although	 there	 were	 important	 acquisition	 events,	 the	18	 most	 striking	 observation	 of	 early	 comparative	 genomic	 analyses	 was	 the	19	 functional	 loss	 of	 a	 large	 number	 of	 genes	 associated	 with	 virulence	 and	20	 metabolism	in	Y.	pestis10.	This	functional	loss	applied	to	about	10%	of	the	genes	21	 in	the	genome,	a	considerably	larger	proportion	of	the	genome	compared	to	gene	22	 gain	events.	The	gene	attrition	was	largely	attributable	to	the	expansion	of	four	23	 major	classes	of	IS	elements	(IS1541,	IS100,	IS285,	IS1661)	leading	to	insertional	24	 gene	 inactivation.	 Other	 processes	 of	 gene	 loss	 included	 deletion	 of	 genes	 and	25	
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loci	and	SNP-based	pseudogene	formation32,33,84,85.	Many	of	the	genes	that	were	1	 functionally	 lost	 encode	 virulence	 factors	 such	 as	 invasin	 and	 YadA,	 and	2	 metabolic	 loci	 involved	 in	 motility,	 dicarboxylic	 amino-acid	 metabolism,	 and	3	 uracil	 transport10,27.	 These	 are	 required	 for	 successful	 colonization	 of	 the	4	 mammalian	 gastrointestinal	 tract,	 a	 niche	 no	 longer	 frequently	 utilised	 by	 Y.	5	
pestis	 as	 it	 emerged	 from	 the	 intestinal	 pathogenic	 Y.	 pseudotuberculosis	 to	6	 colonize	 the	 mid-gut	 of	 fleas	 and,	 in	 mammals,	 to	 become	 a	 more	 systemic	7	 pathogen	invading	the	lymphatic	system27.	8	 The	 importance	 of	 gene	 loss	 in	 the	 evolution	 of	 Y.	 pestis	 has	 recently	 been	9	 exemplified	 by	 studies	 investigating	 key	 mutations	 in	 Y.	 pestis	 that	 mark	 its	10	 evolutionary	 adaptation	 to	 flea-borne	 transmission	 in	 mammals.	 Using	 a	11	 combination	of	comparative	genomics	and	classical	bacterial	genetics,	three	key	12	 loss-of-function	mutations	were	found,	all	of	which	increased	biofilm	formation	13	 in	 the	 flea	 foregut	 in	 a	 cyclic-di-GMP	 dependant	 manner6.	 The	 key	 mutations	14	 were	 in	 two	 genes	 encoding	 EAL-domain	 phosphodiesterases	 (PDE),	 and	 the	15	
rcsA	 gene	 that	 is	 a	 component	 of	 the	 rcs	 regulatory	 network.	 The	 rcs	 system	16	 transcriptionally	 represses	 the	 hms	 locus	 and	 biofilm	 formation.	 PDE	 are	17	 enzymes	 that	 degrade	 cyclic-di-GMP,	 a	 bacterial	 signalling	 molecule	 that	18	 enhances	transcription	of	hms	and	biofilm	formation6.	The	functional	loss	of	the	19	 PDE	 enzymes	 and	 the	 regulator	 repressing	 transcription	 in	 a	 Y.	20	
pseudotuberculosis-ancestor	 led	 to	 the	 emergence	 of	 a	 lineage	 with	 enhanced	21	 ability	to	form	biofilms	in	the	foregut	of	fleas	and	a	resulting	shift	in	pathogenic	22	 lifestyle	of	Y.	pestis6.	The	relatively	recent	emergence	of	Y.	pestis28	 is	 consistent	23	 with	 the	 SNP-based	 pseudogenes,	which	 have	 swept	 to	 fixation	 through	 the	Y.	24	
pestis	 population	 but	 have	 not	 yet	 been	 fully	 deleted30,86.	 Also	 in	 Y.	pestis	 is	 a	25	
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mutation	 in	 the	 ureD	 gene	 that	 leads	 to	 functional	 loss	 of	 urease.	 In	 Y.	1	
pseudotuberculosis	it	has	been	shown	that	the	functional	ureD	encoding	urease	is	2	 associated	 with	 significant	 oral	 toxicity	 in	 the	 flea87,	 hence	 the	 ureD	mutation	3	 may	 play	 a	 contributory	 role	 in	 the	 emergence	 of	Y.	pestis6,87(Fig	 2).	 However,	4	 perhaps	 significantly	 the	 ureD	 mutation	 appears	 to	 be	 a	 reversible	 phase-5	 variable	 mutation	 and	 maybe	 a	 contingency	 gene	 required	 in	 the	 mammalian	6	 host	or	soil	dwelling	stage,	 rather	 than	 the	 insect	vector,	part	of	 its	 life	cycle88.	7	 This	provides	Y.	pestis	the	flexibility	of	retaining	urease	expression,	as	and	when	8	 required.	9	 Genomic	analysis	of	Y.	enterocolitica	showed	that	similar	gene	loss	and	metabolic	10	 restriction	 also	 mark	 the	 evolution	 of	 certain	 subtypes	 of	 this	 species8.	 As	11	 discussed	above	and	shown	in	Figure	3	Y.	enterocolitica	 can	be	subdivided	 into	12	 the	 non-pathogenic	 phylogroup	 PG	 1,	which	 is	 an	 ancestral	 lineage,	 the	 highly	13	 pathogenic	PG	2,	and	PGs	3-5	which	show	limited	pathogenicity	in	mouse	models	14	 but	are	the	most	successful	lineages	in	terms	of	disease	causation	and	are	most	15	 commonly	isolated	from	livestock	and	human	clinical	cases.	PG	6	is	a	rare	lineage	16	 which	has	only	ever	been	isolated	from	wild	hares89,90.	The	evolutionary	descent	17	 from	 host-generalists	 (PGs	 3-5)	 to	 the	 host-restricted	 PG	 6,	 similar	 to	 the	18	 emergence	of	Y.	pestis,	was	accompanied	in	Y.	enterocolitica	by	the	expansion	of	a	19	 single	 IS	 element,	 IS1667,	 as	 well	 as	 functional	 loss	 of	 a	 large	 number	 of	20	 metabolic	 genes.	 The	 impact	 of	 the	 functional	 loss	 of	 metabolic	 loci	 is	21	 particularly	 pronounced	 in	 PG	 6	 and	 is	 thought	 to	 reflect	 its	 extreme	 niche	22	 restriction	to	hares.	Interestingly	the	list	of	metabolic	pathways	inactivated	in	PG	23	 6	is	similar	in	part	to	those	lost	in	Y.	pestis	(cobalamin	biosynthesis,	tetrathionate	24	 respiration	and	the	hydrogenase-4	operon	responsible	 for	the	use	of	molecular	25	
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hydrogen	 in	anaerobic	respiration).	These	mutational	observations	are	directly	1	 supported	by	high	throughput	metabolic	phenotyping	of	PG	68.	2	 Looking	at	 the	 functions	 that	were	 lost	 as	different	 lineages	of	Y.	enterocolitica	3	 diverged	and	adapted	to	new	niches,	one	of	the	earliest	events	 is	 likely	to	have	4	 been	the	decay	of	the	Yersinia	genus	T3SS,	YGT.	YGT	is	an	ancestral	T3SS	present	5	 across	 the	whole	genus	and	 is	distinct	 from	the	Ysc	and	Ysa	T3SSs	acquired	 in	6	 pathogenic	 lineages.	 YGT	 has	 yet	 to	 be	 fully	 characterized	 but	 it	 shares	 a	 high	7	 level	of	sequence	identity	with	the	T3SS	encoded	on	the	SPI-2	genomic	island	in	8	
Salmonella	 enterica,	 which	 was	 a	 key	 acquisition	 required	 for	 intracellular	9	 survival91.	 The	 YGT	 present	 in	 non-pathogenic	 PG	 1	 Y.	enterocolitica	 seems	 to	10	 contain	a	full	complement	of	effector	protein	encoding	genes	compared	with	the	11	 SPI-2	 T3SS8.	 In	 the	 low-pathogenic	 PGs	 3-6	 the	 YGT	 seems	 to	 have	 been	12	 inactivated	 either	 by	 single	 base	 pair	 mutations	 or	 deletion	 of	 the	 secretion	13	 apparatus	genes,	whereas	almost	all	traces	of	the	YGT	have	been	deleted	in	the	14	 highly	pathogenic	PG	2	isolates8.	As	an	example	of	how	dynamic	the	evolution	of	15	 pathogenesis	 is	 through	 gene	 gain	 and	 loss,	 the	 loss	 of	 YGT	 in	 the	 high-16	 pathogenic	PG	2	Y.	enterocolitica	is,	conceptually	at	least,	offset	by	the	gain	of	the	17	 Ysa	 T3SS60.	 A	 full	 functional	 characterisation	 of	 YGT	 is	 now	 required	 to	18	 determine	 if	 the	 selective	 maintenance	 of	 YGT	 in	 PG	 1	 Y.	 enterocolitica	 is	 a	19	 classical	 example	 of	 eco-evo	 principal,	 where	 the	 T3SS	 could	 be	 conferring	 a	20	 protective	benefit	in	a	non-mammalian	host	environment.		21	 IS	 mediated	 gene	 inactivation	 is	 also	 evident	 in	 the	 low-pathogenic	 Y.	22	
enterocolitica	 PG	 3	 lineage	 (comprising	 the	 classically	 entitled	 serotype	 O:3	23	 strains)92,93.	 Molecular	 analysis	 revealed	 a	 IS1667	 had	 inserted	 into	 the	 invA	24	 invasin	 promoter	 region,	 resulting	 in	 the	 formation	 of	 an	 additional	 RovA	25	
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binding	 site	 and	 a	 concomitant	 increase	 in	 expression	 of	 invA94.	 Comparative	1	 analysis	with	 the	other	 low-pathogenic	phylogroups	of	Y.	enterocolitica	 suggest	2	 this	 is	 the	primary	event	 leading	 to	 the	 enhanced	virulence	properties	of	PG	3	3	 isolates	compared	to	PGs	2,	4,	and	593.	As	a	result	of	the	increased	expression	of	4	 invasion	PG	3	 isolates	 can	 colonise	porcine	 tissues	more	 effectively	 than	other	5	 phylogroups,	 and	 as	 result	 PG	 3	 have	 become	 the	 predominant	 isolates	 taken	6	 from	human	clinical	 cases	 in	Europe	over	 the	past	10	years	and	also	dominate	7	 veterinary	epidemiological	surveys95.	8	 	9	
Gene	loss	in	other	Enterobacteriaceae	10	 Functional	gene	loss	in	metabolic	loci	has	been	a	key	event	in	the	Yersinia	genus	11	 that	 mediated	 the	 transition	 from	 ubiquitous	 host-generalist	 lineage	 to	 niche	12	 restricted	and	host-adapted	pathogen	on	at	least	two	occasions.	Once	again	this	13	 observation	 has	 also	 been	made	 in	 Salmonella	 species.	 S.	Typhi96	 shows	many	14	 similarities	with	Y.	pestis,	it	 is	niche	 restricted	 (in	 this	 case	 to	 the	human	host)	15	 and	causes	an	acute	systemic	disease	known	as	typhoid.	Similarly	S.	Gallinarum	16	 and	S.	Pullorum	also	cause	a	typhoid-like	disease	but	are	restricted	to	galliforme	17	 birds97,	 whereas	 S.	Typhimurium	 is	 a	 host-generalist	 causing	 an	 inflammatory	18	 intestinal	 infection	 of	 mammals98.	 Comparative	 genomic	 studies	 of	 these	19	 salmonellae	have	 shown	 that	 functional	 gene	 loss	 in	 loci	 involved	 in	 anaerobic	20	 metabolism	 (more	 specifically	 functional	 loss	 in	 the	 cob/pdu	 and	 ttr	 operons)	21	 was	a	marker	of	the	transition	from	intestinal	pathogen,	like	S.	Typhimurium,	to	22	 invasive	pathogens	such	as	S.	Typhi,	S.	Gallinarum	and	S.	Pullorum99.		23	 In	S.	Typhimurium	under	anaerobic	conditions,	the	cob	genes	encode	the	ability	24	 to	synthesis	cobalamin	(or	vitamin	B12).	Cobalamin	is	required	as	a	cofactor	for	25	
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several	 enzymes	 including	 the	 first	 enzyme	 in	 the	 1,	 2-propanediol	 utilisation	1	 pathway	 (encoded	 by	 pdu	 operon).	 1,2-Propanediol	 is	 a	 by-product	 of	2	 fermentative	growth	on	rhamnose	and	fucose100,	common	constituents	of	plant	3	 cell	walls	and	intestinal	epithelial	cells	(and	therefore	the	gut)101.	The	anaerobic	4	 degradation	 of	 1,2-propanediol	 requires	 tetrathionate	 for	 use	 as	 a	 terminal	5	 electron	 acceptor,	 facilitated	 by	 the	 products	 of	 the	 ttr	 genes102.	 Unlike	 1,2-6	 propanediol,	tetrathionate	was	only	previously	known	to	be	present	in	soils	not	7	 in	the	mammalian	gut.	However,	it	has	been	recently	shown	that	tetrathionate	is	8	 produced	naturally	during	an	inflammatory	response	to	a	Salmonella	infection.	It	9	 is	under	such	conditions	that	the	cob,	pdu	and	ttr	functions	combine	to	provide	a	10	 competitive	growth	advantage	for	S.	Typhimurium,	by	allowing	it	to	outgrow	the	11	 natural	 and	 largely	 fermentative	 gut	 microbiota	 by	 using	 naturally	 occurring	12	 carbon	 sources	 such	 as	 1,2-propanediol	 that	 are	 not	 readily	 fermented103,104	13	 (FIG.	 4).	 As	 the	 invasive	 typhoidal	 Salmonella	 have	 evolved	 away	 from	 an	14	 intestinal	lifestyle,	functions	in	cob/pdu/ttr	operons	have	been	sequentially	lost	15	 and	so	represent	markers	of	 their	change	 in	niche	and	a	movement	away	 from	16	 causing	intestinal	disease	to	a	more	systemic	infection	cycle105.		17	 Although	the	cob/pdu	and	ttr	 loci	are	present	and	 intact	 in	Y.	enterocolitica	and	18	 in	the	majority	of	environmental	Yersinia	species106,	they	are	absent	from	the	Y.	19	
pseudotuberculosis—Y.	 pestis	 complex.	 As	 mentioned	 above,	 tetrathionate	 is	20	 produced	 in	 the	 vertebrate	 inflamed	 gut	 following	 the	 host’s	 response	 to	 S.	21	 Typhimurium	infection,	whereby	the	SPI-1	and	-2	encoded	T3SS	are	essential	for	22	 stimulating	this	inflammatory	response.	Studies	of	Y.	enterocolitica	pathogenesis	23	 have	 shown	 that	 infections	 are	 characterized	 by	 inflammation	 of	 the	 gut107.	24	 Moreover,	inflammation	appears	to	require	pYV108.	It	is	possible	that	by	inducing	25	
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a	 pYV-associated	 inflammatory	 response	 during	 intestinal	 infection109,	 and	 by	1	 expression	 of	 the	 cob/pdu	 and	 ttr	 loci,	 Y.	 enterocolitica	 is	 able,	 like	 S.	2	 Typhimurium,	to	gain	a	metabolic	advantage	over	the	resident	gut	microbiota	by	3	 using	 tetrathionate	 and	 naturally	 occurring	 carbon	 sources	 to	 respire	 under	4	 these	conditions.	The	fact	that	the	cob/pdu	and	ttr	 loci	are	 lost	completely	 in	Y.	5	
pseudotuberculosis	–	Y.	pestis	may	explain	why	these	pathogens	are	incapable	of	6	 causing	 the	 inflammatory	 intestinal	 infection	 observed	 in	 Y.	 enterocolitica,	7	 despite	containing	pYV.		8	 	9	
Summary	and	concluding	remarks		10	 For	 decades	 the	 pathogenic	 yersiniae	 have	 been	 at	 the	 vanguard	 of	11	 understanding	 bacterial	 pathogenesis.	 Examples	 include	 the	 role	 of	 T3SSs42,110	12	 and	 understanding	 the	 molecular	 mechanisms	 by	 which	 intestinal	 pathogens	13	 invade	the	intestinal	epithelium44.	Work	on	the	pathogenic	Yersinia	species	also	14	 drove	the	understanding	of	the	importance	of	plasmids	in	conferring	virulence	to	15	 pathogenic	bacteria12,39.	The	yersiniae	are	also	at	the	forefront	in	developing	our	16	 understanding	 of	 the	 evolution	 of	 mammalian	 pathogenesis.	 Furthermore,	17	
Yersinia	spp.	genomics	has	also	been	at	the	frontline	of	palaeomicrobiology,	with	18	 the	 near	 complete	 reconstruction	 and	 interpretation	 of	 the	 Black	 Death	 and	19	 Justinian	plague	Y.	pestis	genomes	from	ancient	DNA	studies	on	historical	disease	20	 episodes86,111.	 Additionally	 the	 microevolution	 of	 Y.	 pestis	 is	 beginning	 to	 be	21	 unravelled	and	the	distinction	between	ancestral	and	modern	Y.	pestis	has	been	22	 made	 112.	And	very	 recent	 advances	have	 identified	 that	Y.	pestis	was	 a	human	23	 pathogen	 of	 bronze-age	 humans,	 but	 had	 not	 yet	 acquired	 Ymt	 meaning	 it	24	 evolved	the	ability	to	infect	fleas	after	becoming	a	human	pathogen	113.	25	
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The	 position	 of	 Yersinia	 as	 a	 model	 genus	 for	 pathogenesis	 has	 been	 further	1	 cemented	as	it	is	the	first	multispecies	bacterial	genus	for	which	all	species	have	2	 been	sequenced	and	placed	into	phylogenomic	context8.	By	taking	this	approach	3	 coupled	with	high	throughput	metabolic	analyses	using	phenotype	microarrays	4	 it	 was	 possible	 to	 trace	 the	 evolutionary	 origins	 of	 the	 species,	 contextualise	5	 them	and	reveal	the	parallel	evolutionary	paths	of	virulence	in	humans8	(FIG.	5).	6	 The	 genus	 Yersinia	 evolved	 from	 environmental	 ancestors.	 The	 most	 outlying	7	 species	are	the	fish	pathogenic	Y.	ruckeri	(SC	2),	and	newly	classified	lineages	Y.	8	
nurmii	 and	Y.	entomophaga	(SC	 3).	 Previously,	 it	 had	 been	 debated	whether	Y.	9	
ruckeri	 was	 truly	 part	 of	 the	 genus	 Yersinia21,	 however	 this	 has	 now	 been	10	 strengthened	 by	 the	 recognition	 of	 this	 novel	 lineage.	 The	 human	 pathogenic	11	 species	 clusters	emerged	 independently	 following	 the	 common	 themes	of	 ‘add,	12	 stir,	and	reduce’.	Y.	pestis	acquired	its	unique	virulence	plasmids,	an	expansion	of	13	 several	IS	elements	led	to	widespread	genome	rearrangements,	and	considerable	14	 gene	 loss	 can	 be	 observed.	 However,	 in	 the	 Y.	 enterocolitica	 lineages,	 these	15	 themes	 are	 weighted	 differently	 in	 the	 various	 phylogroups.	 PG	 2	 added	 the	16	 high-pathogenicity	island,	and	type	2	and	3	secretions	systems,	and	on	the	other	17	 hand	 lost	 the	 second	 flagella	 cluster	 and	 the	 genus	 T3SS	 YGT.	 PGs	 3-6	 show	18	 genome	rearrangements	 following	 the	expansion	of	 IS1667.	These	phylogroups	19	 also	show	general	loss	of	metabolic	flexibility,	and	in	the	case	of	PG	6	an	extreme	20	 loss	of	metabolic	capability.		21	 Comparative	 analysis	 of	 complete	 genome	 sequence	 data	 sets	 of	 all	22	 representative	 yersiniae	 species	 coupled	 with	 the	 eco-evo	 perspective	 of	23	 bacteria	has	provided	a	greater	understanding	of	the	key	evolutionary	steps	that	24	 led	 to	 the	 emergence	 of	 successful	 mammalian	 pathogens.	 We	 need	 to	 move	25	
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away	 from	 our	 biased	 human-centric	 view	 of	 bacteria	 and	 consider	 more	 the	1	 environmental	context,	habitat	and	niches	of	these	organisms.	2	 Finally,	 the	Yersinia	genus	 data	 shows	 that	 a	 genus-wide	 sequencing	 approach	3	 leads	 to	new	 information	on	 the	distribution	of	virulence-associated	genes	and	4	 on	which	of	 these	 genes	are	genuine	virulence	 factors	 that	 are	appropriate	 for	5	 novel	diagnostic	and	pathogen-targeting	research.	However,	even	with	the	large	6	 number	of	Yersinia	spp.	 isolates	 sequenced	 to	date,	 the	 origin	 and	 reservoir	 of	7	 mobile	genetic	 elements,	 such	as	pYV,	 remain	obscure.	 It	may	be	 that	we	have	8	 only	sequenced	the	tip	of	the	bacterial	iceberg	and	that	future	large	genome	and	9	 microbiome	 studies	 coupled	with	high	 throughput	phenotypic	methods	will	 be	10	 even	 more	 revealing.	 This	 will	 provide	 a	 web	 of	 bacterial	 life,	 the	 inter-11	 relatedness	of	bacteria,	no	doubt	blurring	species	boundaries.	The	genome	data	12	 together	 with	 the	 eco-evo	 perspective	 will	 form	 the	 basis	 of	 how	 and	 why	13	 bacteria	evolve	to	be	more	pathogenic	with	the	potential	to	avert	future	threats	14	 posed	by	old	adversaries	such	as	the	emergence	of	antimicrobial	resistance.		15	
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References	17	 	18	 1.	 Fuchs,	T.,	Bresolin,	G.,	Marcinowski,	L.,	Schachtner,	J.	&	Scherer,	S.	19	 Insecticidal	genes	of	Yersinia	spp.:	taxonomical	distribution,	contribution	20	 to	toxicity	towards	Manduca	sexta	and	Galleria	mellonella,	and	evolution.	21	
BMC	Microbiol.	8,	214	(2008).	22	 	23	 2.	 Lithgow,	K.	V	et	al.	A	general	protein	O-glycosylation	system	within	the	24	
Burkholderia	cepacia	complex		is	involved	in	motility	and	virulence.	Mol.	25	
Microbiol.	92,	116–137	(2014).	26	 	27	 3.	 Pukklay,	P.	et	al.	Involvement	of	EnvZ-OmpR	two-component	system	in	28	 virulence	control	of	Escherichia	coli	in	Drosophila	melanogaster.	Biochem.	29	
Biophys.	Res.	Commun.	438,	306–311	(2013).	30	
24		
	1	 4.	 Kumar,	P.	&	Virdi,	J.	S.	Identification	and	distribution	of	putative	virulence	2	 genes	in	clinical	strains	of	Yersinia	enterocolitica	biovar	1A	by	suppression	3	 subtractive	hybridization.	J.	Appl.	Microbiol.	113,	1263–1272	(2012).	4	 	5	 5.	 Korea,	C.-G.,	Badouraly,	R.,	Prevost,	M.-C.,	Ghigo,	J.-M.	&	Beloin,	C.	6	
Escherichia	coli	K-12	possesses	multiple	cryptic	but	functional	chaperone-7	 usher	fimbriae	with	distinct	surface	specificities.	Environ.	Microbiol.	12,	8	 1957–1977	(2010).	9	 	10	 6.	 Sun,	Y.-C.,	Jarrett,	C.	O.,	Bosio,	C.	F.	&	Hinnebusch,	B.	J.	Retracing	the	11	 evolutionary	path	that	led	to	flea-borne	transmission	of	Yersinia	pestis.	Cell	12	
Host	Microbe	15,	578–586	(2014).	13	 Key	recent	paper	on	the	importance	of	ure	mutations	in	the	emergence	of	Y.	14	
pestis	15	 7.	 Viana,	D.	et	al.	A	single	natural	nucleotide	mutation	alters	bacterial	16	 pathogen	host	tropism.	Nat.	Genet.	47,	361–366	(2015).	17	 	18	 8.	 Reuter,	S.	et	al.	Parallel	independent	evolution	of	pathogenicity	within	the	19	 genus	Yersinia.	Proc	Natl	Acad	Sci	U	S	A	111,	6768–6773	(2014).	20	 First	ever	popualtion	genomic	analysis	of	an	entire	bacterial	genus,	and	key	21	
Yersinia	evolution	paper	22	 9.	 Thomson,	N.	R.	et	al.	The	Complete	Genome	Sequence	and	Comparative	23	 Genome	Analysis	of	the	High	Pathogenicity	Yersinia	enterocolitica	Strain	24	 8081.	PLoS	Genet.	2,	e206	(2006).	25	 	26	 10.	 Chain,	P.	S.	G.	et	al.	Insights	into	the	evolution	of	Yersinia	pestis	through	27	 whole-genome	comparison	with	Yersinia	pseudotuberculosis.	Proc	Natl	28	
Acad	Sci	U	S	A	101,	13826–13831	(2004).	29	 	30	 11.	 Isberg,	R.	R.,	Voorhis,	D.	L.	&	Falkow,	S.	Identification	of	invasin:	A	protein	31	 that	allows	enteric	bacteria	to	penetrate	cultured	mammalian	cells.	Cell	32	
50,	769–778	(1987).	33	 	34	 12.	 Portnoy,	D.	A.	&	Falkow,	S.	Virulence-associated	plasmids	from	Yersinia	35	
enterocolitica	and	Yersinia	pestis.	J.	Bacteriol.	148,	877–883	(1981).	36	 	37	 13.	 Portnoy,	D.	A.,	Moseley,	S.	L.	&	Falkow,	S.	Characterization	of	plasmids	and	38	 plasmid-associated	determinants	of	Yersinia	enterocolitica	pathogenesis.	39	
Infect.	Immun.	31,	775–782	(1981).	40	
25		
	1	 14.	 Rosqvist,	R.,	Hakansson,	S.,	Forsberg,	A.	&	Wolf-Watz,	H.	Functional	2	 conservation	of	the	secretion	and	translocation	machinery	for	virulence	3	 proteins	of	yersiniae,	salmonellae	and	shigellae.	EMBO	J.	14,	4187–4195	4	 (1995).	5	 	6	 15.	 Yao,	T.,	Mecsas,	J.,	Healy,	J.	I.,	Falkow,	S.	&	Chien,	Y.	Suppression	of	T	and	B	7	 lymphocyte	activation	by	a	Yersinia	pseudotuberculosis	virulence	factor,	8	 yopH.	J.	Exp.	Med.	190,	1343–1350	(1999).	9	 	10	 16.	 Monack,	D.	M.,	Mecsas,	J.,	Bouley,	D.	&	Falkow,	S.	Yersinia-induced	11	 apoptosis	in	vivo	aids	in	the	establishment	of	a	systemic	infection	of	mice.	12	
J.	Exp.	Med.	188,	2127–2137	(1998).	13	 	14	 17.	 Boland,	A.	&	Cornelis,	G.	R.	Role	of	YopP	in	suppression	of	tumor	necrosis	15	 factor	alpha	release	by	macrophages	during	Yersinia	infection.	Infect	16	
Immun	66,	1878–1884	(1998).	17	 	18	 18.	 Carniel,	E.	Evolution	of	pathogenic	Yersinia,	some	lights	in	the	dark.	Adv.	19	
Exp.	Med.	Biol.	529,	3–12	(2003).	20	 	21	 19.	 Sprague,	L.	D.	&	Neubauer,	H.	Yersinia	aleksiciae	sp.	nov.	Int.	J.	Syst.	Evol.	22	
Microbiol.	55,	831–835	(2005).	23	 	24	 20.	 Sprague,	L.	D.,	Scholz,	H.	C.,	Amann,	S.,	Busse,	H.-J.	&	Neubauer,	H.	Yersinia	25	
similis	sp.	nov.	Int.	J.	Syst.	Evol.	Microbiol.	58,	952–958	(2008).	26	 	27	 21.	 Sulakvelidze,	A.	Yersiniae	other	than	Y.	enterocolitica,	Y.	28	
pseudotuberculosis,	and	Y.	pestis:	the	ignored	species.	Microbes	Infect.	2,	29	 497–513	(2000).	30	 	31	 22.	 Murros-Kontiainen,	A.	et	al.	Yersinia	nurmii	sp.	nov.	Int	J	Syst	Evol	Micro	61,	32	 2368–2372	(2011).	33	 	34	 23.	 Murros-Kontiainen,	A.	et	al.	Yersinia	pekkanenii	sp.	nov.	Int	J	Syst	Evol	35	
Microbiol	61,	2363–2367	(2011).	36	 	37	 24.	 Hurst,	M.	R.	H.,	Becher,	S.	A.,	Young,	S.	D.,	Nelson,	T.	L.	&	Glare,	T.	R.	Yersinia	38	
entomophaga	sp.	nov.,	isolated	from	the	New	Zealand	grass	grub	Costelytra	39	
zealandica.	Int.	J.	Syst.	Evol.	Microbiol.	61,	844–849	(2011).	40	 	41	
26		
25.	 Merhej,	V.,	Adekambi,	T.,	Pagnier,	I.,	Raoult,	D.	&	Drancourt,	M.	Yersinia	1	
massiliensis	sp.	nov.,	isolated	from	fresh	water.	Int.	J.	Syst.	Evol.	Microbiol.	2	
58,	779–784	(2008).	3	 	4	 26.	 Savin,	C.	et	al.	The	Yersinia	pseudotuberculosis	complex:	characterization	5	 and	delineation	of	a	new	species,	Yersinia	wautersii.	Int.	J.	Med.	Microbiol.	6	
304,	452–463	(2014).	7	 	8	 27.	 Wren,	B.	W.	The	Yersiniae	-	a	model	genus	to	study	the	rapid	evolution	of	9	 bacterial	pathogens.	Nat	Rev	Micro	1,	55–64	(2003).	10	 	11	 28.	 Achtman,	M.	et	al.	Yersinia	pestis,	the	cause	of	plague,	is	a	recently	emerged	12	 clone	of	Yersinia	pseudotuberculosis.	Proc	Natl	Acad	Sci	U	S	A	96,	14043–13	 14048	(1999).	14	 The	initial	paper	that	showed	Y.	pestis	was	a	recently	emerged	clone	of	Y.	15	
pseudotuberculosis	16	 29.	 Achtman,	M.	et	al.	Microevolution	and	history	of	the	plague	bacillus,	17	
Yersinia	pestis.	Proc	Natl	Acad	Sci	U	S	A	101,	17837–17842	(2004).	18	 	19	 30.	 Bos,	K.	I.	et	al.	Yersinia	pestis:	new	evidence	for	an	old	infection.	PLoS	One	20	
7,	e49803	(2012).	21	 	22	 31.	 Chain,	P.	S.	et	al.	Complete	genome	sequence	of	Yersinia	pestis	strains	23	 Antiqua	and	Nepal516:	evidence	of	gene	reduction	in	an	emerging	24	 pathogen.	J	Bacteriol	188,	4453–4463	(2006).	25	 	26	 32.	 Parkhill,	J.	et	al.	Genome	sequence	of	Yersinia	pestis,	the	causative	agent	of	27	 plague.	Nature	413,	523–527	(2001).	28	 	29	 33.	 Deng,	W.	et	al.	Genome	Sequence	of	Yersinia	pestis	KIM.	J.	Bacteriol.	184,	30	 4601–4611	(2002).	31	 	32	 34.	 Savin,	C.	et	al.	Draft	Genome	Sequence	of	a	Clinical	Strain	of	Yersinia	33	
enterocolitica	(IP10393)	of	Bioserotype	4/O:3	from	France.	Genome	34	
Announc.	1,	e00150-12	(2013).	35	 	36	 35.	 Batzilla,	J.,	Hoper,	D.,	Antonenka,	U.,	Heesemann,	J.	&	Rakin,	A.	Complete	37	 genome	sequence	of	Yersinia	enterocolitica	subsp.	palearctica	serogroup		38	 O:3.	J.	Bacteriol.	193,	2067	(2011).	39	 	40	
27		
36.	 Fuchs,	T.	M.,	Brandt,	K.,	Starke,	M.	&	Rattei,	T.	Shotgun	sequencing	of	1	
Yersinia	enterocolitica	strain	W22703	(biotype	2,	serotype		O:9):	genomic	2	 evidence	for	oscillation	between	invertebrates	and	mammals.	BMC	3	
Genomics	12,	168	(2011).	4	 	5	 37.	 Wang,	X.	et	al.	Complete	genome	sequence	of	a	Yersinia	enterocolitica	‘Old	6	 World’	(3/O:9)	strain	and	comparison	with	the	‘New	World’	(1B/O:8)	7	 strain.	J.	Clin.	Microbiol.	49,	1251	(2011).	8	 38.	 Chen,	P.	et	al.	Genomic	characterization	of	the	Yersinia	genus.	Genome	Biol.	9	
11,	R1	(2010).	10	 	11	 39.	 Portnoy,	D.	A.,	Wolf-Watz,	H.,	Bolin,	I.,	Beeder,	A.	B.	&	Falkow,	S.	12	 Characterization	of	common	virulence	plasmids	in	Yersinia	species	and	13	 their	role	in	the	expression	of	outer	membrane	proteins.	Infect.	Immun.	43,	14	 108–114	(1984).	15	 	16	 40.	 Cornelis,	G.	R.	&	Wolf-Watz,	H.	The	Yersinia	Yop	virulon:	a	bacterial	system	17	 for	subverting	eukaryotic	cells.	Mol.	Microbiol.	23,	861–867	(1997).	18	 	19	 41.	 Grosdent,	N.,	Maridonneau-Parini,	I.,	Sory,	M.-P.	&	Cornelis,	G.	R.	Role	of	20	 Yops	and	Adhesins	in	Resistance	of	Yersinia	enterocolitica	to	Phagocytosis.	21	
Infect.	Immun.	70,	4165–4176	(2002).	22	 	23	 42.	 Cornelis,	G.	R.	&	Wolf-Watz,	H.	The	Yersinia	Yop	virulon:	a	bacterial	system	24	 for	subverting	eukaryotic	cells.	Mol.	Microbiol.	23,	861–867	(1997).	25	 	26	 43.	 Bohn,	E.	et	al.	Gene	expression	patterns	of	epithelial	cells	modulated	by	27	 pathogenicity	factors	of	Yersinia	enterocolitica.	Cell.	Microbiol.	6,	129–141	28	 (2004).	29	 	30	 44.	 Miller,	V.	L.	&	Falkow,	S.	Evidence	for	two	genetic	loci	in	Yersinia	31	
enterocolitica	that	can	promote	invasion	of	epithelial	cells.	Infect.	Immun.	32	
56,	1242–1248	(1988).	33	 	34	 45.	 Pierson,	D.	E.	&	Falkow,	S.	The	ail	gene	of	Yersinia	enterocolitica	has	a	role	35	 in	the	ability	of	the	organism	to	survive	serum	killing.	Infect.	Immun.	61,	36	 1846–1852	(1993).	37	 	38	 46.	 Biedzka-Sarek,	M.,	Venho,	R.	&	Skurnik,	M.	Role	of	YadA,	Ail,	and	39	 Lipopolysaccharide	in	Serum	Resistance	of	Yersinia	enterocolitica	Serotype	40	 O:3.	Infect.	Immun.	73,	2232–2244	(2005).	41	 	42	
28		
47.	 Carniel,	E.	Plasmids	and	pathogenicity	islands	of	Yersinia.	Curr.	Top.	1	
Microbiol.	Immunol.	264,	89–108	(2002).	2	 	3	 48.	 Pepe,	J.	C.	&	Miller,	V.	L.	Yersinia	enterocolitica	invasin:	A	primary	role	in	4	 the	initiation	of	infection.	Proc	Natl	Acad	Sci	U	S	A	90,	6473–6477	(1993).	5	 	6	 49.	 Schubert,	S.,	Fischer,	D.	&	Heesemann,	J.	Ferric	enterochelin	transport	in	7	
Yersinia	enterocolitica:	molecular	and	evolutionary	aspects.	J.	Bacteriol.	8	
181,	6387–6395	(1999).	9	 	10	 50.	 Tomich,	M.,	Planet,	P.	J.	&	Figurski,	D.	H.	The	tad	locus:	postcards	from	the	11	 widespread	colonization	island.	Nat.	Rev.	Microbiol.	5,	363–375	(2007).	12	 	13	 51.	 Iriarte,	M.	et	al.	The	Myf	fibrillae	of	Yersinia	enterocolitica.	Mol.	Microbiol.	14	
9,	507–520	(1993).	15	 	16	 52.	 Delor,	I.	&	Cornelis,	G.	R.	Role	of	Yersinia	enterocolitica	Yst	toxin	in	17	 experimental	infection	of	young	rabbits.	Infect	Immun	60,	4269–4277	18	 (1992).	19	 	20	 53.	 Hinnebusch,	B.	J.	et	al.	Role	of	Yersinia	Murine	Toxin	in	Survival	of	Yersinia	21	
pestis	in	the	Midgut	of	the	Flea	Vector.	Science	(80	).	296,	733	(2002).	22	 	23	 54.	 Zimbler,	D.	L.,	Schroeder,	J.	A.,	Eddy,	J.	L.	&	Lathem,	W.	W.	Early	emergence	24	 of	Yersinia	pestis	as	a	severe	respiratory	pathogen.	Nat.	Commun.	6,	7487	25	 (2015).	26	 Recent	publication	showing	key	role	of	Pla	in	the	evolution	of	the	unique	27	 virulence	of	Y.	pestis	28	 55.	 Lesic,	B.	et	al.	Excision	of	the	high-pathogenicity	island	of	Yersinia	29	
pseudotuberculosis	requires	the	combined	actions	of	its	cognate	integrase	30	 and	Hef,	a	new	recombination	directionality	factor.	Mol.	Microbiol.	52,	31	 1337–1348	(2004).	32	 	33	 56.	 Schubert,	S.,	Picard,	B.,	Gouriou,	S.,	Heesemann,	J.	&	Denamur,	E.	Yersinia	34	 high-pathogenicity	island	contributes	to	virulence	in	Escherichia	coli	35	 causing	extraintestinal	infections.	Infect	Immun	70,	5335–5337	(2002).	36	 	37	 57.	 Carniel,	E.,	Guilvout,	I.	&	Prentice,	M.	Characterization	of	a	large	38	 chromosomal	‘high-pathogenicity	island’	in	biotype	1B	Yersinia	39	
enterocolitica.	J.	Bacteriol.	178,	6743–6751	(1996).	40	 	41	
29		
58.	 Bobrov,	A.	G.	et	al.	The	Yersinia	pestis	siderophore,	yersiniabactin,	and	the	1	 ZnuABC	system	both	contribute	to	zinc	acquisition	and	the	development	of	2	 lethal	septicaemic	plague	in	mice.	Mol.	Microbiol.	93,	759–775	(2014).	3	 	4	 59.	 Paauw,	A.,	Leverstein-van	Hall,	M.	A.,	van	Kessel,	K.	P.	M.,	Verhoef,	J.	&	Fluit,	5	 A.	C.	Yersiniabactin	reduces	the	respiratory	oxidative	stress	response	of	6	 innate	immune	cells.	PLoS	One	4,	e8240	(2009).	7	 	8	 60.	 Haller,	J.	C.,	Carlson,	S.,	Pederson,	K.	J.	&	Pierson,	D.	E.	A	chromosomally	9	 encoded	type	III	secretion	pathway	in	Yersinia	enterocolitica	is	important	10	 in	virulence.	Mol.	Microbiol.	36,	1436–1446	(2000).	11	 	12	 61.	 Matsumoto,	H.	&	Young,	G.	M.	Proteomic	and	functional	analysis	of	the	13	 suite	of	Ysp	proteins	exported	by	the	Ysa	type	III	secretion	system	of	14	
Yersinia	enterocolitica	Biovar	1B.	Mol.	Microbiol.	59,	689–706	(2006).	15	 	16	 62.	 Young,	B.	M.	&	Young,	G.	M.	Evidence	for	Targeting	of	Yop	Effectors	by	the	17	 Chromosomally	Encoded	Ysa	Type	III	Secretion	System	of	Yersinia	18	
enterocolitica.	J.	Bacteriol.	184,	5563–5571	(2002).	19	 	20	 63.	 Walker,	K.	A.,	Maltez,	V.	I.,	Hall,	J.	D.,	Vitko,	N.	P.	&	Miller,	V.	L.	A	phenotype	21	 at	last:	essential	role	for	the	Yersinia	enterocolitica	Ysa	type	III		secretion	22	 system	in	a	Drosophila	melanogaster	S2	cell	model.	Infect.	Immun.	81,	23	 2478–2487	(2013).	24	 	25	 64.	 Perry,	R.	D.,	Pendrak,	M.	L.	&	Schuetze,	P.	Identification	and	cloning	of	a	26	 hemin	storage	locus	involved	in	the	pigmentation		phenotype	of	Yersinia	27	
pestis.	J.	Bacteriol.	172,	5929–5937	(1990).	28	 	29	 65.	 Hinnebusch,	B.	J.,	Perry,	R.	D.	&	Schwan,	T.	G.	Role	of	the	Yersinia	pestis	30	 hemin	storage	(hms)	locus	in	the	transmission	of	plague	by	fleas.	Science	31	
273,	367–370	(1996).	32	 	33	 66.	 Schroder,	O.	&	Wagner,	R.	The	bacterial	regulatory	protein	H-NS--a	34	 versatile	modulator	of	nucleic	acid	structures.	Biol.	Chem.	383,	945–960	35	 (2002).	36	 	37	 67.	 Cathelyn,	J.	S.,	Ellison,	D.	W.,	Hinchliffe,	S.	J.,	Wren,	B.	W.	&	Miller,	V.	L.	The	38	 RovA	regulons	of	Yersinia	enterocolitica	and	Yersinia	pestis	are	distinct:	39	 evidence	that	many	RovA-regulated	genes	were	acquired	more	recently	40	 than	the	core	genome.	Mol.	Microbiol.	66,	189–205	(2007).	41	
30		
Publication	showing	the	marked	difference	in	the	RovA	regulons	of	the	1	 pathogenic	Yersinia	2	 68.	 Ellison,	D.	W.,	Lawrenz,	M.	B.	&	Miller,	V.	L.	Invasin	and	beyond:	regulation	3	 of	Yersinia	virulence	by	RovA.	Trends	Microbiol.	12,	296–300	(2004).	4	 	5	 69.	 Bucker,	R.,	Heroven,	A.	K.,	Becker,	J.,	Dersch,	P.	&	Wittmann,	C.	The	6	 pyruvate-tricarboxylic	acid	cycle	node:	a	focal	point	of	virulence	control	in	7	 the	enteric	pathogen	Yersinia	pseudotuberculosis.	J.	Biol.	Chem.	289,	8	 30114–30132	(2014).	9	 The	only	published	version	of	the	Y.	pseudotuberculosis	RovA	regulon	10	 70.	 Bohme,	K.	et	al.	Concerted	actions	of	a	thermo-labile	regulator	and	a	11	 unique	intergenic	RNA	thermosensor	control	Yersinia	virulence.	PLoS	12	
Pathog.	8,	e1002518	(2012).	13	 A	comprehensive	analysis	of	the	mechanism	of	RovA/YmoA	regulation	14	 71.	 Koo,	J.	T.,	Alleyne,	T.	M.,	Schiano,	C.	A.,	Jafari,	N.	&	Lathem,	W.	W.	Global	15	 discovery	of	small	RNAs	in	Yersinia	pseudotuberculosis	identifies	Yersinia-16	 specific	small,	noncoding	RNAs	required	for	virulence.	Proc.	Natl.	Acad.	Sci.	17	
U.	S.	A.	108,	E709–17	(2011).	18	 	19	 72.	 Quade,	N.	et	al.	Structural	basis	for	intrinsic	thermosensing	by	the	master	20	 virulence	regulator	RovA	of	Yersinia.	J.	Biol.	Chem.	287,	35796–35803	21	 (2012).	22	 	23	 73.	 Kapatral,	V.	et	al.	Gene	array	analysis	of	Yersinia	enterocolitica	FlhD	and	24	 FlhC:	regulation	of	enzymes	affecting	synthesis	and	degradation	of	25	 carbamoylphosphate.	Microbiol	150,	2289–2300	(2004).	26	 	27	 74.	 Perry,	R.	D.	et	al.	Temperature	regulation	of	the	hemin	storage	(Hms+)	28	 phenotype	of	Yersinia	pestis	is	posttranscriptional.	J.	Bacteriol.	186,	1638–29	 1647	(2004).	30	 	31	 75.	 Fälker,	S.,	Schmidt,	M.	A.	&	Heusipp,	G.	Altered	Ca2+	Regulation	of	Yop	32	 Secretion	in	Yersinia	enterocolitica	after	DNA	Adenine	Methyltransferase	33	 Overproduction	Is	Mediated	by	Clp-Dependent	Degradation	of	LcrG.	J.	34	
Bacteriol.	188,	7072–7081	(2006).	35	 	36	 76.	 Grabenstein,	J.	P.,	Marceau,	M.,	Pujol,	C.,	Simonet,	M.	&	Bliska,	J.	B.	The	37	 Response	Regulator	PhoP	of	Yersinia	pseudotuberculosis	Is	Important	for	38	 Replication	in	Macrophages	and	for	Virulence.	Infect.	Immun.	72,	4973–39	 4984	(2004).	40	
31		
	1	 77.	 Rebeil,	R.	et	al.	Induction	of	the	Yersinia	pestis	PhoP-PhoQ	regulatory	2	 system	in	the	flea	and	its		role	in	producing	a	transmissible	infection.	J.	3	
Bacteriol.	195,	1920–1930	(2013).	4	 	5	 78.	 Pisano,	F.	et	al.	Influence	of	PhoP	and	intra-species	variations	on	virulence	6	 of	Yersinia	pseudotuberculosis	during	the	natural	oral	infection	route.	PLoS	7	
One	9,	e103541	(2014).	8	 	9	 79.	 Nuss,	A.	M.	et	al.	A	direct	link	between	the	global	regulator	PhoP	and	the	10	 Csr	regulon	in	Y.	pseudotuberculosis	through	the	small	regulatory	RNA	11	 CsrC.	RNA	Biol.	11,	580–593	(2014).	12	 	13	 80.	 Fookes,	M.	et	al.	Salmonella	bongori	provides	insights	into	the	evolution	of	14	 the	Salmonellae.	PLoS	Pathog.	7,	e1002191	(2011).	15	 Key	publication	highlighting	the	evolution	of	pathogenesis	in	Salmonella	16	 81.	 Navarre,	W.	W.	et	al.	Co-regulation	of	Salmonella	enterica	genes	required	17	 for	virulence	and	resistance		to	antimicrobial	peptides	by	SlyA	and	18	 PhoP/PhoQ.	Mol.	Microbiol.	56,	492–508	(2005).	19	 	20	 82.	 Ali,	S.	S.	et	al.	Silencing	by	H-NS	potentiated	the	evolution	of	Salmonella.	21	
PLoS	Pathog.	10,	e1004500	(2014).	22	 Key	publication	showing	the	importance	of	H-NS	in	the	evolution	of	SPI	mediated	23	 pathogenesis	in	Salmonella	24	 83.	 Pallen,	M.	J.	&	Wren,	B.	W.	Bacterial	pathogenomics.	Nature	449,	835–842	25	 (2007).	26	 	27	 84.	 Morelli,	G.	et	al.	Yersinia	pestis	genome	sequencing	identifies	patterns	of	28	 global	phylogenetic	diversity.	Nat.	Genet.	42,	1140-3	(2010).		29	 Comprehensive	analysis	of	the	pattern	on	fine	scale	and	ongoing	recent	30	 evolution	in	Y.	pestis	31	 85.	 Song,	Y.	et	al.	Complete	genome	sequence	of	Yersinia	pestis	strain	91001,	32	 an	isolate	avirulent	to	humans.	DNA	Res	11,	179–197	(2004).	33	 	34	 86.	 Bos,	K.	I.	et	al.	A	draft	genome	of	Yersinia	pestis	from	victims	of	the	Black	35	 Death.	Nature	478,	506–510	(2011).	36	 	37	 87.	 Chouikha,	I.	&	Hinnebusch,	B.	J.	Silencing	urease:	a	key	evolutionary	step	38	
32		
that	facilitated	the	adaptation	of	Yersinia	pestis	to	the	flea-borne	1	 transmission	route.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	111,	18709–18714	(2014).	2	 	3	 88.	 Sebbane,	F.,	Devalckenaere,	A.,	Foulon,	J.,	Carniel,	E.	&	Simonet,	M.	4	 Silencing	and	reactivation	of	urease	in	Yersinia	pestis	is	determined	by	one	5	 G	residue	at	a	specific	position	in	the	ureD	gene.	Infect.	Immun.	69,	170–6	 176	(2001).	7	 	8	 89.	 Aleksic,	S.,	Wuthe,	H.H.	Yersinia	enterocolitica	serovar	2a,	wb,	3:b,c	biovar	9	 5	in	hares	and	sheep.	Berl	Munch	Tierarztl	Wochenschr	110,	176	(1997).	10	 	11	 90.	 Swaminathan,	B.,	Harmon,	M.	C.	&	Mehlman,	I.	J.	Yersinia	enterocolitica.	J.	12	
Appl.	Bacteriol.	52,	151–183	(1982).	13	 	14	 91.	 Shea,	J.	E.,	Hensel,	M.,	Gleeson,	C.	&	Holden,	D.	W.	Identification	of	a	15	 virulence	locus	encoding	a	second	type	III	secretion	system	in	Salmonella	16	 Typhimurium.	Proc	Natl	Acad	Sci	U	S	A	93,	2593–2597	(1996).	17	 	18	 92.	 Schaake,	J.	et	al.	Essential	role	of	invasin	for	colonization	and	persistence	19	 of	Yersinia	enterocolitica	in	its	natural	reservoir	host,	the	pig.	Infect.	20	
Immun.	82,	960–969	(2014).	21	 	22	 93.	 Schaake,	J.	et	al.	Human	and	animal	isolates	of	Yersinia	enterocolitica	show	23	 significant	serotype-specific	colonization	and	host-specific	immune	24	 defense	properties.	Infect.	Immun.	81,	4013–4025	(2013).	25	 	26	 94.	 Uliczka,	F.	et	al.	Unique	cell	adhesion	and	invasion	properties	of	Yersinia	27	
enterocolitica	O:3,	the		most	frequent	cause	of	human	Yersiniosis.	PLoS	28	
Pathog.	7,	e1002117	(2011).	29	 	30	 95.	 Valentin-Weigand,	P.	Heesemann,	J.	Dersch,	P.	Unique	virulence	properties	31	 of	Yersinia	enterocolitica	O:3	-	An	emerging	zoonotic	pathogen	using	pigs	32	 as	preferred	reservoir	host.	Int.	J.	Med.	Microbiol.	14,	00090–3	(2014).	33	 	34	 96.	 Parkhill,	J.	et	al.	Complete	genome	sequence	of	a	multiple	drug	resistant	35	
Salmonella	enterica	serovar	Typhi	CT18.	Nature	413,	848–852	(2001).	36	 	37	 97.	 Thomson,	N.	R.	et	al.	Comparative	genome	analysis	of	Salmonella	38	 Enteritidis	PT4	and	Salmonella	Gallinarum	287/91	provides	insights	into	39	 evolutionary	and	host	adaptation	pathways.	Genome	Res.	18,	1624–1637	40	 (2008).	41	 	42	
33		
98.	 McClelland,	M.	et	al.	Complete	genome	sequence	of	Salmonella	enterica	1	 serovar	Typhimurium	LT2.	Nature	413,	852–856	(2001).	2	 	3	 99.	 Nuccio,	S.-P.	&	Baumler,	A.	J.	Comparative	analysis	of	Salmonella	genomes	4	 identifies	a	metabolic	network	for	escalating	growth	in	the	inflamed	gut.	5	
MBio	5,	e00929–14	(2014).	6	 	7	 100.	 Badia,	J.,	Ros,	J.	&	Aguilar,	J.	Fermentation	mechanism	of	fucose	and	8	 rhamnose	in	Salmonella	Typhimurium	and	Klebsiella	pneumoniae.	J.	9	
Bacteriol.	161,	435–437	(1985).	10	 	11	 101.	 Bry,	L.,	Falk,	P.	G.,	Midtvedt,	T.	&	Gordon,	J.	I.	A	model	of	host-microbial	12	 interactions	in	an	open	mammalian	ecosystem.	Science	273,	1380–1383	13	 (1996).	14	 	15	 102.	 Price-Carter,	M.,	Tingey,	J.,	Bobik,	T.	A.	&	Roth,	J.	R.	The	alternative	electron	16	 acceptor	tetrathionate	supports	B12-dependent	anaerobic		growth	of	17	
Salmonella	enterica	serovar	typhimurium	on	ethanolamine	or	1,2-18	 propanediol.	J.	Bacteriol.	183,	2463–2475	(2001).	19	 	20	 103.	 Winter,	S.	E.	et	al.	Gut	inflammation	provides	a	respiratory	electron	21	 acceptor	for	Salmonella.	Nature	467,	426–429	(2010).	22	 Key	account	of	the	role	of	cob/pdu/ttr	in	inflammation	and	intestinal	23	 colonisation	by	Salmonella	24	 104.	 Thiennimitr,	P.	et	al.	Intestinal	inflammation	allows	Salmonella	to	use	25	 ethanolamine	to	compete	with	the	microbiota.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	26	
108,	17480–17485	(2011).	27	 	28	 105.	 Langridge,	G.	C.	et	al.	Patterns	of	genome	evolution	that	have	accompanied	29	 host	adaptation	in	Salmonella.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	112,	863–868	30	 (2015).	31	 	32	 106.	 Prentice,	M.	B.	et	al.	Cobalamin	synthesis	in	Yersinia	enterocolitica	8081.	33	 Functional	aspects	of	a	putative	metabolic	island.	Adv.	Exp.	Med.	Biol.	529,	34	 43–46	(2003).	35	 	36	 107.	 Rabson,	A.	R.,	Hallett,	A.	F.	&	Koornhof,	H.	J.	Generalized	Yersinia	37	
enterocolitica	infection.	J.	Infect.	Dis.	131,	447–451	(1975).	38	 	39	 108.	 Lian,	C.	J.,	Hwang,	W.	S.,	Kelly,	J.	K.	&	Pai,	C.	H.	Invasiveness	of	Yersinia	40	
enterocolitica	lacking	the	virulence	plasmid:	an	in-vivo	study.	J.	Med.	41	
34		
Microbiol.	24,	219–226	(1987).	1	 	2	 109.	 Buret,	A.,	O’Loughlin,	E.	V,	Curtis,	G.	H.	&	Gall,	D.	G.	Effect	of	acute	Yersinia	3	
enterocolitica	infection	on	small	intestinal	ultrastructure.	Gastroenterology	4	
98,	1401–1407	(1990).	5	 	6	 110.	 Tardy,	F.	et	al.	Yersinia	enterocolitica	type	III	secretion-translocation	7	 system:	channel	formation	by	secreted	Yops.	Embo	J.	18,	6793–6799	8	 (1999).	9	 	10	 111.	 Wagner,	D.	M.	et	al.	Yersinia	pestis	and	the	plague	of	Justinian	541-543	AD:	11	 a	genomic	analysis.	Lancet.	Infect.	Dis.	14,	319–326	(2014).	12	 	13	 112.	 Cui,	Y.	et	al.	Historical	variations	in	mutation	rate	in	an	epidemic	pathogen,	14	
Yersinia	pestis.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	110,	577–582	(2013).	15	 	16	 113.	Rasmussen,	S.	et	al.	Early	divergent	strains	of	Y.	pestis	in	Eurasia	5000	years	17	 ago.	Cell.	163,	1-12	(2015).	18	 	19	 114.	 Hall,	M.	et	al.	Use	of	whole-genus	genome	sequence	data	to	develop	a	20	 multilocus	sequence	typing	tool	that	accurately	identifies	Yersinia	isolates	21	 to	the	species	and	subspecies	levels.	J.	Clin.	Microbiol.	53,	35–42	(2015).	22	 	23	 115.	 Bottone,	E.	J.	Yersinia	enterocolitica:	overview	and	epidemiologic	24	 correlates.	Microbes	Infect.	1,	323–333	(1999).	25	 	26	 116.	 Barnes,	P.	D.,	Bergman,	M.	A.,	Mecsas,	J.	&	Isberg,	R.	R.	Yersinia	27	
pseudotuberculosis	disseminates	directly	from	a	replicating	bacterial	pool	28	 in	the	intestine.	J.	Exp.	Med.	203,	1591–1601	(2006).	29	 	30	 117.	 Bottone,	E.	J.	Yersinia	enterocolitica:	the	charisma	continues.	Clin.	31	
Microbiol.	Rev.	10,	257–276	(1997).	32	 	33	 118.	 Sebbane,	F.,	Jarrett,	C.	O.,	Gardner,	D.,	Long,	D.	&	Hinnebusch,	B.	J.	Role	of	34	 the	Yersinia	pestis	plasminogen	activator	in	the	incidence	of	distinct	35	 septicemic	and	bubonic	forms	of	flea-borne	plague.	Proc.	Natl.	Acad.	Sci.	U.	36	
S.	A.	103,	5526–5530	(2006).	37	 	38	 119.	 Sha,	J.	et	al.	Characterization	of	an	F1	deletion	mutant	of	Yersinia	pestis	39	 CO92,	pathogenic	role	of	F1	antigen	in	bubonic	and	pneumonic	plague,	and	40	 evaluation	of	sensitivity	and	specificity	of	F1	antigen	capture-based	41	 dipsticks.	J.	Clin.	Microbiol.	49,	1708–1715	(2011).	42	43	
35		
Box	1:	Phylogenomics	of	Yersinia	species:	approaches	and	major	findings.	1	 Traditionally,	 bacteria	 are	 speciated	 using	 limited	 biochemical	 tests	 that	 are	2	 based	on	the	phenotypic	expression	or	non-expression	of	a	trait.	This	can	lead	to	3	 problems	 in	 standardising	 methods,	 and	 the	 potential	 to	 mutate	 the	 trait	 can	4	 impact	on	the	phenotype.	Genomic	information	is	less	ambiguous,	and	variations	5	 within	 genes	 under	 neutral	 selection	 can	 be	 used	 to	 infer	 evolutionary	6	 relationships,	providing	a	 robust	 framework	 that	 is	 independent	of	phenotypic	7	 variation.	 For	 the	 genus	Yersinia,	 84	 housekeeping	 genes	were	 identified,	 that	8	 showed	between	10-25%	SNP	divergence	between	Y.	pestis	and	Y.	enterocolitica8.	9	 These	 criteria	meet	 those	 of	 housekeeping	 genes	 used	 for	 the	 design	 of	multi-10	 locus	sequence	typing	(MLST)	schemes114,	so	that	the	accumulation	of	variation	11	 reflects	 the	 history	 of	 the	 genus,	 and	 a	maximum	 likelihood	 phylogeny	 can	 be	12	 estimated.	 Furthermore,	 Bayesian	 analysis	 of	 the	 population	 structure	 was	13	 employed	 to	 identify	 defined	 species	 clusters	 (SC8).	 This	means	 that	 statistical	14	 probabilities	 are	 calculated	 to	 describe	 the	 variation	 hidden	 within	 the	15	 population,	and	does	not	only	consider	the	sequence	of	the	84	genes	as	a	whole	16	 but	as	separate	gene	entities.	Some	of	the	species	clusters	thus	described	contain	17	 multiple	species	as	defined	by	classical	techniques,	such	as	SCs	13	and	14.	On	the	18	 other	 hand,	 other	 species	 like	Y.	frederiksenii,	 that	 show	heterogeneity	 in	 their	19	 phenotype,	are	distributed	over	several	SCs	(SCs	8,	9,	and	14).	This	highlights	the	20	 limitations	 of	 biochemical	 tests	 that	 fail	 to	 accurately	 reflect	 the	 relationships	21	 between	 the	different	species.	The	analysis	also	emphasizes	 the	position	of	 the	22	 pathogenic	 species.	 The	 human	 pathogenic	 species	 are	 positioned	 at	23	 diametrically	opposite	ends	of	the	tree,	with	the	fish	pathogen	Y.	ruckeri	(green)	24	 forming	a	third	outlying	SC.	Even	though	no	classical	root	of	the	tree	is	given,	Y.	25	
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ruckeri	might	be	considered	an	out	group	since	its	position	within	the	genus	has	1	 previously	 been	 under	 debate.	 The	 position	 of	 Y.	pseudotuberculosis—Y.	pestis	2	 and	 Y.	 enterocolitica	 nevertheless	 supports	 independent	 evolution	 of	 their	3	 pathogenic	potential.	4	 It	 must	 be	 noted	 however,	 that	 speciation	 might	 involve	 more	 than	 purely	5	 genomic	 evidence,	 as	Y.	pestis	 and	Y.	pseudotuberculosis	 are	highly	 similar	on	a	6	 genomic	 level,	 yet	exhibit	markedly	different	mechanisms	of	disease	as	well	 as	7	 niche	preference	and	life	style.	8	
	9	
Box	2:	Mechanisms	of	pathogenesis	in	Yersinia	spp.	10	 The	three	human-pathogenic	species	of	Yersinia	share	a	key	genetic	component	11	 in	their	ability	to	cause	disease,	a	large	virulence	plasmid	named	pYV	(plasmid	of	12	
Yersinia	 Virulence).	 Though	 commonly	 thought	 of	 as	 a	 single	 entity,	 pYV	 is	13	 actually	 highly	 variable	 between	 species	 and	 strains	 of	 species,	 containing	14	 different	 origin	 of	 replications	 and	 showing	 variable	 genetic	 architecture8,12.	15	 What	is	common	amongst	them	all	 is	a	 large	genetic	 locus	encoding	for	the	Ysc	16	 type	 III	 secretion	 system	 (T3SS),	 responsible	 for	 the	 targeted	 delivery	 of	 Yop	17	 effector	proteins	into	host	cells.	The	Yops	are	the	key	virulence	factor	in	all	three	18	 of	the	pathogenic	species.	Upon	contact	with	host	macrophages	Yops	are	injected	19	 into	 the	 host	 cells,	 resulting	 in	 silencing	 of	 the	 pro-inflammatory	 cytokine	20	 response	and	apoptotic	death	of	the	infected	macrophages40.		21	
Y.	 enterocolitica/Y.	 pseudotuberculosis	 –	 are	 zoonotic	 infectious	 agents	 which	22	 cause	inflammatory	intestinal	disease	associated	with	ingestion	via	consumption	23	 of	undercooked	or	contaminated	pork	products	and	vegetables115.	The	bacteria	24	 enter	 the	 small	 intestine	 where	 they	 attach	 to	 the	 intestinal	 epithelium.	25	
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Numerous	virulence	factors	have	been	implicated	in	this	including	the	Myf,	YadA,	1	 and	 Ail	 adhesins	 as	 well	 as	 flagella18.	 The	 invasin	 protein	 then	 triggers	2	 internalisation	 of	 the	 bacteria,	 which	 translocate	 across	 the	 epithelium48.	3	 Bacteria	 replicating	 in	 the	 intestinal	 tract	 can	 also	 disseminate	 to	 lymphatic	4	 tissues	via	infection	and	silencing	of	phagocytic	immune	cells116.	As	a	result,	this	5	 infection	 is	 often	 diagnosed	 as	 pseudo-appendicitis,	 and	 can	 lead	 to	6	 septicaemia117.		7	
Y.	 pestis	 –	unlike	 Y.	 enterocolitica	 and	 Y.	 pseudotuberculosis,	 does	 not	 have	 an	8	 intestinal	 phase	 to	 its	 infection-cycle.	 Y.	 pestis	 host	 reservoir	 is	 rodent	 fleas,	9	 where	it	forms	a	biofilm	in	their	foregut65.	When	the	flea	next	takes	a	blood	meal	10	 the	biofilm	is	regurgitated	into	the	host	prey.	If	injected	into	the	bloodstream	the	11	 bacteria	immediately	encounter	phagocytic	immune	cells	triggering	activation	of	12	 the	 Ysc	 system	 and	 host-cell	 silencing,	 leading	 to	 septicaemic	 plague118.	 If	13	 injected	 into	 the	 extravascular	 part	 of	 the	 dermis,	 the	 bacteria	 travel	 to	 the	14	 lymph	nodes	where	an	acute	infection	is	established	leading	to	the	formation	of	15	 painful	 swellings	 at	 the	 lymph	 nodes,	 or	 buboes118.	 This	 is	 known	 as	 bubonic	16	 plague.	 If	 untreated	 the	 infection	 will	 spill	 back	 into	 the	 bloodstream	 with	17	 bacteria	travelling	to	the	lungs,	where	pneumonic	plague	is	established.	Y.	pestis	18	 has	acquired	additional	plasmids,	pPla	and	pFra	which	play	pivotal	roles	 in	the	19	 insect-infection	and	systemic-infection	phase	of	the	organism53,54,119.		20	 	21	 		22	 Figure	 1:	 Diagrammatic	 comparison	 of	 the	 RovA/YmoA	 regulons	 of	 Y.	23	
enterocolitica,	Y.	pseudotuberculosis,	and	Y.	pestis.	 Genes	 activated	 by	 RovA	 are	24	 shown	 in	green,	and	genes	repressed	by	RovA	are	shown	 in	red.	Genes	 in	bold	25	
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share	 common	 RovA	 regulatory	 patterns	 between	 Y.	pseudotuberculosis	and	 Y.	1	
pestis.	Also	shown	are	 the	 loci	activated	and	repressed	by	RovA	 in	a	conserved	2	 fashion.	 This	 shows	 that	 the	 key	 acquired	 pYV	 plasmid	 (denoted	 by	 the	 lcrF	3	 gene)	 is	 the	 only	 locus	 showing	 conserved	 RovA	 repression.	 The	 invasion	4	 encoding	 gene	 inv	 is	 also	 shown	 as	 activated	 by	 RovA	 in	 a	 conserved	 fashion,	5	 however	 the	 asterix	 indicates	 that	 this	 is	 not	 entirely	 conserved,	 as	 inv	 is	 a	6	 pseudogene	in	Y.	pestis.	The	lack	of	common	activated	and	repressed	genes	in	the	7	 3	species	by	a	conserved	regulatory	mechanism	highlights	the	key	role	played	by	8	 the	RovA/YmoA	systems	in	controlling	expression	of	lineage	defining	loci.		9	
	10	 Figure	 2:	 Gene	 loss	 in	 the	 emergence	 of	 Y.	 pestis	 from	 Y.	 pseudotuberculosis.	11	 Deletion	events	in	genes	encoding	motility	and	the	metabolic	ability	to	colonise	12	 the	mammalian	 intestinal	 tract	 in	 ancestral	Y.	pseudotuberculosis	occurred	 as	 a	13	 result	of	a	shift	away	from	that	environment	towards	an	insect-vector	phase	of	14	 the	 life-cycle.	 As	 a	 result	 there	 was	 selection	 for	 deletion	 of	 genes	 encoding	15	 insect-toxins,	 including	 SNP-based	 reversible	 inactivation	 of	 the	 ureD	 gene,	16	 encoding	urease,	which	has	high	oral	toxicity	in	fleas.	For	transmission	from	the	17	 flea	 to	 occur	 Y.	 pestis	 must	 form	 biofilms	 in	 the	 flea	 foregut.	 SNP	 based	18	 pseudogene	 inactivation	 of	 rcsA	 resulted	 in	 increased	 expression	 of	 the	 hms	19	 operon	 which	 encodes	 biofilm	 formation.	 Similarly	 SNP	 based	 pseudogene	20	 inactivation	 occurred	 in	 a	 gene	 encoding	 a	 phosphodiesterase.	 The	 product	 of	21	 this	 gene	 degrades	 cyclic-di-GMP,	 a	 molecule	 that	 acts	 as	 a	 transcriptional	22	 activator	of	hms	and	biofilm	formation.		23	 	24	
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Figure	3:	Gene	gain	and	loss	in	the	Y.	enterocolitica	species	complex.	The	diagram	1	 shows	how	 the	species	 is	organised	 into	phylogenetically	distinct	phylogroups,	2	 which	parallel	LPS	structure	and	serotype.	PG	1	is	most	similar	to	the	ancestral	Y.	3	
enterocolitica.	 The	 emergence	of	 pathogenicity	 in	 the	 species	 is	marked	by	 the	4	 acquisition	of	pYV,	and	 in	PG	2	the	Ysa	T3SS.	The	YGT	T3SS	 is	 lost	 from	all	 the	5	 pathogenic	 phylogroups.	 The	 other	 significant	 event	 is	 the	 acquisition	 of	6	 serotype	specific	LPS	operons	 in	each	of	 the	pathogenic	phylogroups.	PG	3	has	7	 become	the	dominant	isolate	from	pig	reservoirs	and	human	disease	cases,	and	8	 has	a	deletion	in	the	Flag-2	secondary	flagella	genes	as	well	as	an	insertion	in	the	9	 invasin	promoter,	which	increases	transcription	of	this	key	virulence	factor.	10	 	11	 Figure	4:	Enteropathogenic	Salmonella	and	Yersinia	species	use	cob/pdu	and	ttr	12	 loci	to	outcompete	normal	intestinal	flora	during	mammalian	infection.	The	cob	13	 genes	encode	cobalamin	biosynthesis.	Cobalamin	activates	enzymes	encoded	by	14	
pdu	that	degrade	or	ethanolamine.	This	process	requires	the	use	of	tetrathionate	15	 as	a	terminal	electron	acceptor	in	anaerobic	respiration,	the	respiration	of	which	16	 is	 encoded	 by	 the	 ttr	 genes.	 The	 enteropathogenic	 Yersinia	 and	 Salmonella	17	 species	 induce	 inflammation	during	 infection.	This	 inflammation	 leads	 to	over-18	 production	of	ethanolamine	by	the	intestinal	epithelium,	which	creates	a	hostile	19	 environment	 for	 gastrointestinal	 commensal	 bacteria,	 but	 a	 favorable	 growth	20	 environment	 for	 the	 enteropathogens.	 This	 leads	 to	 the	 enteropathogens	21	 outcompeting	 the	 normal	 flora	 and	 overgrowth	 and	 colonization	 by	 the	22	 pathogens.		23	 	24	
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Figure	 5:	 A	 diagrammatic	 overview	 of	 the	 evolution	 of	 pathogenesis	 in	 the	1	
Yersinia	genus,	highlighting	key	gene	gain	and	gene	loss	events	in	the	formation	2	 of	each	of	 the	pathogenic	 lineages.	Acquisition	of	pYV	occurs	 independently	on	3	 two	occasions	within	Y.	enterocolitica	PG	2	and	PGs	3-6,	as	well	as	additionally	in	4	 a	 Y.	 pseudotuberculosis	 ancestor.	 These	 two	 human-pathogenic	 lineages	 have	5	 emerged	 on	 independent	 occasions	 from	 environmental	 generalists	 following	6	 similar	 themes	 of	 gene	 gain,	 gene	 loss,	 metabolic	 reduction,	 and	 genome	7	 rearrangements.		8	
	9	
Glossary	10	 Compensatory	mutation	–	Mutations	that	occur	to	offset	detrimental	gene	gain,	11	 loss,	or	mutation	events	in	independent	parts	of	the	genome.	12	 Conjugation	 -	The	 transfer	of	DNA	–	usually	plasmids	–	between	organisms	via	13	 direct	cell-to-cell	contact	or	a	bridge	between	cells.	14	 Cyclic-di-GMP	 –	 Secondary	 messenger	 molecule	 used	 in	 bacterial	 signal	15	 transduction	 to	 modulate	 gene	 expression	 in	 response	 to	 environmental	16	 perturbations.	17	 Eco-evo	perspective	–	A	perspective	in	which	organisms	are	evaluated	broadly	in	18	 the	 light	 of	 evolution	 and	 ecology,	 rather	 than	 narrow	 constraints	 of	 their	19	 behaviour	in	the	laboratory	or	in	human	infection	20	 F1	capsular	protein	–	Protein	antigen	found	on	the	surface	of	pathogenic	Yersinia	21	 thought	to	modulate	targeting	of	bacteria	to	sites	of	infection.	22	 Genomic	islands	-	Large	genetic	regions	that	are	part	of	the	accessory	gene	pool.	23	 They	 form	 the	 horizontally	 acquired	 part	 of	 a	 genome	 encoding	 one	 of	 more	24	 functional	groups	of	genes.	They	are	frequently	associated	with	tRNA	genes	and	25	
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are	 flanked	 by	 repeat	 structures,	 and	 contain	 mobility	 genes	 coding	 for	1	 integrases	or	transposases	required	for	chromosomal	integration	and	excision.	2	 Horizontal	 gene	 transfer	 -	 The	 transfer	 of	 DNA,	 frequently	 cassettes	 of	 genes,	3	 between	organisms.	This	process	is	in	contrast	to	vertical	gene	transfer,	which	is	4	 much	more	common	and	occurs	when	genetic	material	is	passed	from	parent	to	5	 offspring	or,	more	generally,	from	ancestor	to	descendent.	6	 Integrons	-	A	cassette	of	genes	encoding	a	site-specific	recombinase/integrase,	a	7	 recombination	recognition	site,	and	a	promoter.	Often	found	in	conjunction	with	8	 other	genes	such	as	antibiotic	resistance	genes.	9	 IS	element	-	The	simplest	type	of	transposable	element	in	a	bacterium.	Insertion	10	 Sequence	elements	encode	only	the	gene	required	for	its	own	transposition,	and	11	 is	flanked	by	repeats.	12	 LEE	pathogenicity	island	–	Mobile	genetic	element	encoding	for	a	T3SS	found	in	13	 enteropathogenic	and	enterohaemmorhagic	E.	coli.	Injects	effector	molecule	into	14	 host	intestinal	epithelial	cells	resulting	in	actin	rearrangement	and	formation	of	15	 characteristic	attaching	and	effacing	lesions.	16	 MarR/SlyA	–	family	of	transcriptional	regulators	found	in	bacteria.	Generally	act	17	 as	activators	of	transcription	by	alleviating	HN-S	mediated	repression.	18	 Natural	 transformation	 -	 Direct	 uptake	 of	 DNA	 from	 the	 environment	 and	19	 incorporation	of	this	genetic	material	into	the	chromosome	by	competent	cells.	20	 Palaeomicrobiology	 –	 Study	 of	 ancient	 infectious	 disease	 outbreaks	 by	21	 recovering	nucleic	acid	sequences	from	ancient	human	remains.	22	 Phenotypic	 microarray	 analysis	 –	 High-throughput,	 automated	 assays	 that	23	 determine	 the	 ability	 of	 bacterial	 strains	 to	metabolise	metabolic	 substrates	 in	24	 parallel.		25	
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Phylogenomic	 analysis	 –	 The	 use	 of	 whole	 genome	 sequences	 to	 create	1	 phylogenetic	 trees	 and	 infer	 high-resolution	 evolutionary	 patterns.	 This	 is	 in	2	 contrast	to	using	phylogenetic	markers	such	as	16S.	3	 Pla	–	Plasminogen	activator	protein	found	in	Y.	pestis	and	encoded	on	a	Y.	pestis	4	 specific	plasmid.	Protease	required	for	pneumonic	infection.		5	 Promiscuous	(regulon)	–	Promiscuous	regulators	assume	transcriptional	control	6	 of	 large	 numbers	 of	 genes	 (regulons)	 that	 do	 not	 come	 under	 fine-scale	7	 environmental	control.	Examples	are	HN-S,	IHF,	and	FIS.		8	 Salmonids	-	Relating	to	salmon	and	trout	fish.	9	 Sideophore	-	Compound	enabling	highly	efficient	capture	of	exogenous	iron.	10	 Transduction	 -	 The	 transfer	 of	DNA	 –	 frequently	 cassettes	 of	 genes	 –	 between	11	 organisms	with	the	help	of	phages.	12	 Two-component	regulatory	system	-	Bacterial	sensor-kinase	systems	composed	13	 of	 an	 outer	 membrane	 sensor,	 which	 autophosphorylates	 in	 response	 to	 a	14	 specific	 environmental	 stimulus.	 This	 then	 leads	 to	 phosphorylation	 of	 a	15	 response	regulator	that	up	and	down	regulates	expression	of	operons.	16	 Type	 III	 secretion	 system	 (T3SS)	 –	 A	 mechanism	 by	 which	 bacteria	 export	17	 proteins.	 Often	 responsible	 for	 the	 translocation	 of	 bacterial	 effector	 proteins	18	 from	 pathogenic	 or	 symbiotic	 bacteria	 directly	 into	 the	 cytoplasm	 of	 their	19	 eukaryotic	 host,	 where	 these	 proteins	 subvert	 eukaryotic-cell	 functions	 to	 the	20	 advantage	of	the	bacterium.	21	 Verotoxin	 –	 Shiga-like	 toxin	 produced	 by	 verotoxigenic	 E.	 coli.	 AB5	 toxin	 that	22	 targets	cells	in	the	renal	glomeruli	leading	to	kidney	damage.	23	 Ymt	–	Yersinia	murine	toxin.	First	characterised	as	a	determinant	of	lethality	in	24	 mice,	now	known	to	play	a	crucial	role	in	the	ability	of	Y.	pestis	to	survive	in	fleas.	25	
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Yops	–	Yersinia	outer	proteins	are	a	set	of	effector	proteins	secreted	by	the	Ysc	1	 T3SS	found	on	the	pYV	plasmid	in	pathogenic	Yersinia	spp.	Yops	are	injected	into	2	 phagocytic	cells	where	the	silence	the	production	of	pro-inflammatory	cytokines	3	 and	induce	apoptosis	in	the	infected	cell.		4	 	 	5	
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